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Failure of atherosclerotic plaques can lead to potentially life threatening 
clinical events such as myocardial infarction (MI), stroke, or transient ischemic 
attack (TIA). The most frequently described plaque failure mechanism is tensile 
rupture of the fibrous cap; however, often during angioplasty another plaque failure 
mechanism occurs in which the atherosclerotic plaque separates from the internal 
elastic lamina (IEL). This study aims assess the material strength of atherosclerotic 
lesions using mechanical concepts. 
To assess likelihood of plaque dissection at the vessel wall, adhesion 
strength was assessed in both mouse and human specimens using plaque 
delamination experiments. Measuring plaque adhesion in transgenic mouse 
models can be useful in understanding the contributions to plaque adhesion from 
specific proteins. Comparing these results to similar delamination experiments in 
human plaques aids in understanding the similarities between mechanical 
properties of plaques in the two species. 
To further understand adhesive failure at the plaque-IEL interface, the 
contributions of adhesive proteins to the mechanical strength of the plaque-IEL 
interface were investigated. The results from a novel semi-quantitative plaque 
immunoblotting technique and measurements of adhesive strength of thin protein 
films combine to provide an estimate of the adhesive strength of relevant matrix 
vi 
proteins at approximate ex vivo concentrations. The adhesion strength in thin 
protein films is much lower than that determined from in situ plaque adhesion 
experiments and suggests that bridging fibers, rather than adhesive proteins, are 
likely to be responsible for the adhesive strength of the plaque-IEL interface.  
In addition to plaque adhesion strength, plaque stability was also assessed 
by investigating the resistance to tensile rupture of the fibrous caps in human 
carotid endarterectomy specimens. Mechanical strength of fibrous caps was 
assessed during failure by calculating crack tip opening displacement (CTOD) and 
stress in the uncracked segment (UCS) in miniature single edge notched tensile 
(MSENT) specimens. The results show that fibrous caps with greater collagen 
content exhibit more brittle behavior and fail at a higher stress and a smaller CTOD 
than those with a lower collagen content, which exhibit a more ductile response. 
Knowledge of the collagen content in the fibrous cap prior to surgical intervention 
could predict the mechanical response of the fibrous cap and aid in determining 
the optimal treatment plan.  
Fracture toughness was used to assess plaque resistance to two different 
failure mechanisms: 1) plaque delamination at the plaque-IEL interface and 2) 
tensile rupture of the fibrous cap. Collagen is a vital structural component of 
atherosclerotic plaques and is crucial in determining the mechanical response of 
fibrous caps. Fibrillar forms of collagen, such as collagen I, or other fibrillar 
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Atherosclerotic plaque rupture can lead to myocardial infarction (MI) or 
ischemic stroke, which are two of the leading causes of death in the United States 
[1]. There were approximately 7.6 million MIs in 2014 in the US alone. It is 
estimated that by 2030 there will be 3.4 million strokes in American adults, a 20% 
increase in prevalence since 2012. The total cost of cardiovascular disease and 
stroke in the United States in 2010 is estimated to be over $315 billion [2].  
1.1 Structure and composition of the arterial wall 
There are two main types of arteries: elastic arteries and muscular arteries.  
Elastic arteries, such as the aorta, typically consist of three concentric tissue 
layers: the intima, the media, and the adventitia. Figure 1, used with permission 
from reference [3], shows a diagram of a typical elastic artery. The intima is the 
innermost layer and primarily consists of a single layer of endothelial cells which 
rest on a basement membrane and subendothelial layer. In diseased 
atherosclerotic arteries, the intima thickens in the subendothelial layer with 
inflammatory cells, lipids, calcium deposits, and collagen fibers. This thickening 
can be so severe that in these cases the intima actually bears a significant portion 




of a network of collagen fibers, elastin, and smooth muscle cells (SMCs). A series 
of elastic lamellae separate the media into several layers of a fiber reinforced 
material. The innermost elastic layer, the internal elastic lamina, separates the 
media from the intima, and the outermost, the external elastic lamina, separates 
the media from the adventitia. Collagen and elastin are the major load bearing 
extracellular matrix (ECM) proteins present in arteries [3]–[5]. Elastin, a primary 
component of the media, allows for the reversible stretching of the artery, which 
repeatedly occurs in elastic arteries due to the pulsatile blood flow originating from 
the heart. Elastic fibers appear wavy and unengaged at low pressures; however, 
they straighten at physiological blood pressures and are likely the primary load 
bearing elements [5], [6].  The adventitia is the outermost layer of the artery and is 
primarily composed of thick bundles of collagen, fibroblasts (fibrocytes), 
macrophages, and resident stem cells. Collagen, unlike elastin, primarily engages 
at higher than normal physiological pressures to prevent rupture of the artery [3], 
[5] - [7].  
 
Figure 1.1 A typical elastic artery. The intima is designated by ‘I’, the media ‘M’, 




Though collagen and elastin provide most of the load bearing support, 
glycoproteins, such as fibrillin-1, fibronectin, or other glycoproteins with adhesive 
properties, may be involved in physically binding the layers of the artery together. 
Fibrillin-1 is the major component of individual microfibrils which associate with 
mature elastic fibers [8]; however, they are found in the absence of elastin in some 
locations, such as the ciliary zonula of the eye and superficial regions of the skin 
[9]. Microfibrils, even without the presence of elastin, have been shown to 
contribute to the structural integrity of the tissue [10]. They have been found linking 
the abluminal surface of endothelial cells to the internal elastic lamina in neonatal 
rat aorta [11]. Therefore, microfibrils may be important structural elements in 
vascular tissue, even in the absence of elastin. There is also evidence to support 
adhesive proteins, such as fibronectin, as important structural proteins in vascular 
tissue. Fibronectin has a multidomain structure which enables binding to cell 
surfaces as well as to other ECM molecules, such as collagen, microfibrils, and 
proteoglycans [11]–[13].  Therefore, fibronectin may be a structural link between 
cells and ECM components. Other, unidentified adhesive and fibrillar proteins may 
also contribute to the structural integrity of healthy and diseased vasculature. 
There are many adhesive glycoproteins, e.g. laminin, osteopontin, 
thrombospondin, in tissue. In fact, an entire class of proteins, matricellular proteins, 
may be important to consider. While matricellular proteins are not primary 
structural proteins like collagen or elastin, they can modulate cell-matrix 






Development and progression of atherosclerotic lesions 
The development of atherosclerosis is a decades-long process that begins 
with thickening of the intima. This thickening, known at adaptive intimal thickening, 
primarily consists of SMCs, proteoglycans, and elastin, and is likely an adaptation 
to maintain homeostatic flow and shear stress [15]. In 1995 Williams and Tabas 
described the “response-to-retention” hypothesis, still a valid hypothesis of 
atherogenesis today [16]. The first step of atherogenesis, according to the 
response-to-retention hypothesis, is sequestration of lipoproteins in the thickened 
intima by binding to proteoglycans in the ECM. Lipoproteins bound to 
proteoglycans are more likely to be oxidized, which leads to uptake by macrophage 
cells. The process is advanced by macrophages secreting additional 
proteoglycans that further increase lipid retention in the vascular wall [17]. 
Macrophages ingest and store lipoproteins, which are rich in cholesterol, resulting 
in the formation of foam cells  [18], [19]. Foam cells sometimes ingest too much 
cholesterol to store as cholesterol esters, resulting in high levels of free cholesterol. 
High levels of free cholesterol trigger apoptosis in cells, resulting in necrosis of the 
foam cells  [19].  When the resulting necrotic core is covered by a thin fibrous cap, 
the plaque configuration is particularly vulnerable to plaque rupture, potentially 
leading to myocardial infarction and stroke [20]–[22]. 
There are several key processes involved in the development of 




and necrosis of the lipid core. The order and interaction between these processes 
is not well understood. Repeated cycles of atherogenic events at different time 
points during plaque development likely contribute to the heterogeneous nature 
and unpredictable progression of atherosclerotic plaques.  One potential sequence 
of atherosclerotic lesion development is shown in Figure 1.2.  
 
Figure 1.2 The progression of atherosclerosis. The histological images were 
stained with Movat’s pentachrome. This image is reused with permission from [22]. 
 
There is some disagreement regarding the initiation of atherosclerotic 
lesions. While intimal xanthoma and adaptive intimal thickening are both 
considered non-atherosclerotic due to their limited clinical impact, the sequence 
and interaction between these two states is not well known. Some studies argue 
that intimal xanthomas are a separate initiation pathway to atherosclerotic lesions 
[20], while other studies hypothesize that xanthomas develop at sites of adaptive 




progress by accumulating lipids and macrophages within the intima, developing a 
distinct fibrous cap composed of SMCs and collagen, and accumulating calcium 
deposits within the lesion [22]. Many of these processes are concurrent and the 
exact processes are difficult to sequence; however, various stages can be 
classified using the morphological characteristics described in the next section. 
Classification of atherosclerotic lesions 
There are several methods of classification of atherosclerotic lesions; 
however, the most widely referenced classification scheme linking plaque 
morphology to clinical disease state was first introduced by Virmani, et al. in 2000 
[20]. Based on this classification, there are seven categories of lesions.  
Virmani, et al. proposed two potential initiation mechanisms in 
atherosclerosis: intimal thickening and intimal xanthoma. An intimal xanthoma is 
characterized by an accumulation of macrophages in the intima of the vessel, 
whereas intimal thickening primarily consists of SMCs, proteoglycans, and elastin.  
The intermediate stage is termed pathologic intimal thickening (PIT) and is 
characterized by lipid presence in the lesion without necrosis. The lipid pools are 
covered with a thin layer of proteoglycans and SMCs, with small numbers of 
macrophages [18], [20]. The fibrous cap atheroma contains a true necrotic core 
along with a distinct fibrous cap which consists of SMCs, collagen, proteoglycans, 
and typically higher levels of macrophages and lymphocytes than those in PIT 
lesions. The thin cap fibroatheroma (TCFA) is given a special distinction because 




of calcification within the lesion leads to two additional morphological 
classifications. The first is calcified nodules, which are dense nodules of calcium 
that disrupt the fibrous cap and are associated with thrombi. Fibrocalcific plaques, 
on the other hand, are characterized by a heavily calcified plaque with a relatively 
small necrotic core and an intact fibrous cap without any thrombus present [20]. 
Material failure of atherosclerotic lesions 
As the atherosclerotic disease state progresses, the likelihood increases of 
plaque failure resulting in a clinical event, such as myocardial infarction or stroke. 
The most frequent and well described mechanism of plaque failure is plaque 
rupture, during which a tear in the fibrous cap exposes the highly thrombogenic 
necrotic core material. This mechanism generally occurs in lesions characterized 
as a thin-cap fibroatheroma (TCFA) and is responsible for about 60% of all cases 
involving thrombotic sudden coronary death. A second mechanism is plaque 
erosion, which typically occurs in intimal thickening or fibroatheromas with little to 
no necrotic core. However, the exact mechanism underlying plaque erosion is 
unknown [20]–[23].  
The size of the necrotic core is thought to play an important role in the risk 
associated with TCFAs.  Necrotic core material is lacking sufficient collagen to 
provide mechanical support to the vessel which can lead to a greater stress applied 
to the fibrous cap.  Additionally, the necrotic core may erode the thin fibrous cap, 
increasing the stress even further.  Ultimately, higher stresses in a material 




Oftentimes, the thrombosis resulting from plaque rupture or plaque erosion 
does not result in vessel occlusion and remains clinically silent.  However, the 
healing of the rupture or erosion sites promotes further occlusion of the vessel, 
and subsequent ruptures or erosions frequently occur.  Healed rupture sites are 
generally characterized by a disrupted fibrous cap filled in with proteoglycans or 
collagen III. There also may be multi-layering of necrotic core and lipid.  Healed 
erosion sites, on the other hand, typically do not have a necrotic core or a disrupted 
fibrous cap.  Instead, multi-layering of collagen and SMCs with proteoglycans is 
evident [22], [23]. 
1.3 Current clinical interventions 
The two most common interventional treatments for atherosclerotic carotid 
artery stenosis are carotid artery stenting (CAS) and carotid endarterectomy 
(CEA). CEA is an invasive surgical procedure in which the plaque and the 
underlying media are dissected from the carotid artery and a vascular patch is 
placed over the remaining adventitia.  Carotid endarterectomy (CEA) is generally 
considered the standard treatment for carotid artery stenosis, but recently carotid 
artery stenting (CAS) has been suggested as an alternative, less invasive, 
technique.  
In CAS, a catheter is inserted into the carotid artery and a small balloon is 
inflated at the lesion site. The goal is to flatten the plaque and to increase the lumen 
area; however, in some cases this results in plaque dissection at the plaque 




stent over the dissected tissue to hold the intimal and medial surfaces together to 
recreate a smooth lumen [24]–[26]. CAS has been shown to result in more strokes 
during the periprocedural period than CEA [27]–[29].  
Estimation of the plaque mechanical properties could help assess the 
optimal treatment for carotid artery stenosis. The increased risk of stroke during 
the periprocedural period following CAS may be reduced if the material properties 
of the plaque are considered prior to selecting a treatment. The timing of the 
procedure can be optimized if we can predict which plaques are more prone to 
rupture.  
1.4 Fracture mechanics and biological tissues 
The goal of this study is to use the principles of fracture mechanics and 
material failure to gain an understanding of the failure of atherosclerotic lesions. 
Assessing the adhesion strength between atherosclerotic plaques and the 
underlying arterial wall may provide insight into the mechanism of plaque 
dissection or delamination that sometimes occurs during balloon angioplasty.  
Additionally, measuring the fracture toughness through the fibrous cap will 
characterize its ability to resist a tear and ultimately to avoid rupture.  
Fracture mechanics can be used to characterize the cohesive behavior of 
materials, such as the tissue within the fibrous cap, as well as the properties of the 
interface between two adhesive materials, such as the plaque-internal elastic 




Two that will be used in this study are energy release rate and crack tip opening 
displacement (CTOD). 
The energy release rate is defined as the energy required to extend a crack, 
per unit of crack extension, and is based on the concept that crack extension will 
occur when the energy available for crack growth exceeds the resistance of the 
material [30]–[33]. Though not used previously to characterize fracture toughness 
in vascular tissue, CTOD was first proposed by Wells at the British Welding 
Institute to characterize failure under elastic-plastic yielding conditions [14]. Wells 
observed that plastic deformation resulted in blunting at the crack tip, and that the 
extent of crack-tip blunting increased in proportion to the toughness of the material. 
Later, Dawes showed that CTOD is linearly related to the J-integral in elastic-
plastic conditions and that both are valid fracture parameters [15].  
1.5 Previous Studies 
Fracture mechanics has been used to characterize biological tissues in the 
past. Several groups have previously used energy release rate to characterize 
fracture toughness within biological tissues [30], [34], [35]. Wang et al. developed 
a protocol to measure the plaque adhesion strength in mice and to determine the 
effects of specific proteins on plaque adhesion using transgenic mice [36], [37]. 
This technique can be applied to investigate the potential contributions of 
additional proteins to plaque adhesion strength. 
Collagen VIII is a non-fibrillar collagen upregulated during atherosclerotic 




be important to investigate the effect of collagen VIII on plaque adhesion strength. 
SMC migration and proliferation are both decreased in apolipoprotein E; collagen 
VIII triple knockout (ApoE-/- ;Col8-/-) mice when compared to apolipoprotein E 
knockout (ApoE-/-) mice [41], [42]. SMCs adhere less strongly to collagen VIII than 
to collagen I, and it is hypothesized that increased deposition of collagen VIII 
masks collagen I and allows increased migration of SMCs in atherosclerotic 
lesions [41]. Atherosclerotic lesions of ApoE-/-;Col8-/- mice  have thinner fibrous 
caps and larger necrotic cores than those of ApoE-/- Col 8+/+ mice due to decreased 
migration and proliferation of SMCs [42]. Morphological characteristics including 
larger necrotic cores and thinner fibrous caps are associated with increased plaque 
vulnerability in humans [21], [43] and this may also be true in mice. In order to truly 
assess the effects of collagen VIII on plaque stability, however, mechanical testing 
of the atherosclerotic plaques must be conducted in both ApoE-/- and ApoE-/-;Col8-
/- mice. Additionally, in order for the mouse plaque adhesion strength results to be 
considered clinically relevant, plaque adhesion strength must also be measured in 
human atherosclerotic plaques.  
Measurements of plaque adhesion strength can provide some insights into 
failure at the plaque-IEL or fibrous cap-lipid core interfaces, but further 
investigation is necessary in order to understand the more detailed failure 
mechanism. Potential failure mechanisms include breakage of fibers that bind two 
tissue layers or breakage of bonds between adhesive proteins and other ECM 




IEL interface and even less known about the mechanical properties of these 
proteins. 
There have been several studies that have investigated the mechanical 
properties of human atherosclerotic plaques using uniaxial extension tests [44]–
[49], compression tests [49]–[51], and uniaxial extension tests in both 
circumferential and axial orientations [52], [53]. Most of these studies have 
determined the stress-strain response under specified loading conditions; 
however, few studies have measured other mechanical properties of these tissues. 
Ultimate tensile strength (UTS) has been measured by a few groups in whole 
plaques [46]–[48], and once in isolated fibrous caps [54]. While knowledge of the 
mechanical properties of whole plaques has some utility, properties of isolated 
fibrous cap specimens are more relevant to assessing plaque vulnerability to 
rupture. In general, both strength and toughness need to be assessed to 
understand material failure. Many engineering materials that exhibit high strength 
are brittle and exhibit low fracture toughness and vice versa, though this is not 
always the case, especially in complex materials such as atherosclerotic plaques. 
To the author’s knowledge, there have been no reports of fracture toughness 
measurements in human fibrous caps. Thus, this represents an important gap in 
the literature. 
1.6 Specific Aims 
The overall goal of this project is to assess the mechanical failure of 




insight into the failure mechanisms and potentially determine the relevant failure 
criteria. Understanding the mechanism of plaque failure is the first step in 
developing a method or treatment to prevent plaque failure. Therefore, this work 
may be an important step in advancing the therapeutic treatment options for 
atherosclerosis.  
Specific Aim 1: Determine the effects of collagen VIII on plaque adhesion strength 
in mice and compare plaque adhesion strength in mice to fibrous cap adhesion 
strength in human carotid endarterectomy specimens. 
In order to build on previous plaque adhesion strength measurements, two 
additional sets of experiments were performed. The first set of experiments 
measured plaque adhesion strength in transgenic mice to assess the contributions 
of collagen VIII to adhesion strength. The second set of experiments was 
performed on human atherosclerotic plaques to determine whether or not the 
mouse plaque adhesion strength measurements are representative of plaque 
adhesion strength in humans. 
Specific Aim 2: Determine the role of adhesive proteins at the plaque-IEL 
interface. 
The goal of specific aim 2 is to investigate separation of adhesive proteins 
as a potential failure mechanism at the plaque-IEL interface using a novel 
approach. Immunohistochemistry and semi-quantitative plaque immunoblotting 
were used to identify and to approximately quantify several adhesive proteins at 




model of atherosclerosis. The adhesive strength between thin films of these 
proteins and vascular ECM was measured using rigid double cantilever beam 
(RDCB) experiments. By comparing the energy release rate in these experiments 
to the energy release rate calculated from previous in situ measurements of plaque 
delamination from the IEL, the role of the adhesive proteins can be determined.  If 
the energy release rates are greatly different between these two sets of 
experiments, we can conclude that other structures, such as bridging fibers, may 
play a significant role in the adhesion strength between the plaque and the IEL.  
Specific Aim 3: Characterize the fracture toughness of atherosclerotic fibrous 
caps in human carotid endarterectomy (CEA) specimens. 
Fracture mechanics concepts were used to characterize fracture toughness 
in atherosclerotic fibrous caps for the first time. In particular, crack tip opening 
displacement (CTOD) and the stress in the uncracked segment (UCS) at failure 
initiation were evaluated in each fibrous cap specimen. Additionally, the collagen 







ATHEROSCLEROTIC PLAQUE ADHESION STRENGTH IN 
TRANSGENIC MICE AND HUMAN CAROTID ENDARTERECTOMY 
SPECIMENS
2.1 Introduction 
Atherosclerotic plaque failure is one of the leading causes of myocardial 
infarction and stroke. There are at least two potential failure mechanisms for 
atherosclerotic plaques.  The first involves tensile rupture of the fibrous cap and 
the second, which is prominent during angioplasty, involves plaque delamination 
from the internal elastic lamina (IEL) at the plaque shoulder.  During balloon 
angioplasty, a catheter is inserted into the blood vessel and a small balloon is 
inflated at the lesion site.  The goal is to flatten the plaque and increase the lumen 
area; however, in some cases this procedure results in intimal dissection at the 
plaque shoulder.  These localized dissections are commonly treated with the 
implantation of a stent over the dissected tissue to hold the intimal and medial 
surfaces together and to recreate a smooth lumen [24]–[26]. 
Plaque adhesion strength has previously been measured in apolipoprotein 
E knockout (ApoE-/-) mice [36] and in apolipoprotein E matrix metalloproteinase-




strengthens plaque adhesion, potentially by increasing the formation of gaps in the 
IEL to allow for fiber bridging between the intima and the media. The methodology 
developed by Wang, et al. will be used in the present work to study the effects of 
collagen VIII on plaque adhesion strength by examining plaque adhesion strength 
in both ApoE-/- and apolipoprotein E; collagen VIII triple knockout (ApoE-/- Col8-/-) 
mice. 
Collagen VIII is a non-fibrillar collagen that is upregulated during 
atherosclerotic lesion development [38]–[40]. Smooth muscle cell (SMC) migration 
and proliferation are both decreased in ApoE-/- Col8-/- mice when compared to 
ApoE-/- mice [42], [55]. SMCs adhere less strongly to collagen VIII than to collagen 
I, and it is hypothesized that increased deposition of collagen VIII masks collagen 
I and allows increased migration of SMCs in atherosclerotic lesions [55].  
Atherosclerotic lesions of ApoE-/- Col8-/- mice  have thinner fibrous caps and larger 
necrotic cores than those of ApoE-/- Col 8+/+ mice due to decreased SMC migration 
and proliferation [42]. Morphological characteristics including larger necrotic cores 
and thinner fibrous caps are associated with increased plaque vulnerability in 
humans [21] and this may also be true in mice. In order to truly assess plaque 
stability, however, mechanical testing of the atherosclerotic plaques must be 
conducted in both ApoE-/- and ApoE-/- Col8-/- mice. 
The current study will build on the previous work by Wang et al. [36], [37] 
further by investigating adhesion strength of human fibrous caps in carotid 
endarterectomy specimens. Performing the experiments on human tissue allows 




assessed. This analysis will also assist in determining whether or not the results 
from mouse plaque adhesion strength experiments can be translated to human 
atherosclerotic plaques.  
2.2 Materials and Methods 
2.2.1 Plaque adhesion strength in transgenic mice 
 All procedures involving vertebrate animals were approved by the USC 
Institutional Animal Care and Use Committee. Four C57Bl6 congenic ApoE-/- mice 
and seven ApoE-/- Col8-/- mice were fed a high-fat (40% of total calories) diet for 
six months to develop advanced aortic atherosclerotic plaques. Mice were 
euthanized by carbon dioxide asphyxiation and perfused with heparinized saline 
at physiological pressure for five minutes. The adhesion strength between the 
atherosclerotic plaque and the IEL was measured with cyclic peeling experiments, 
based on a previously published protocol [36], [37]. In brief, the aorta was opened 
longitudinally to visualize the atherosclerotic plaques. A small initial flaw was made 
at the proximal end of one plaque and the free edge was gripped with forceps 
which were mounted in a  Bose Electroforce 3200 Test Instrument (Bose Corp., 
Framingham, MA). The Bose Test Instrument has two grips.  One grip clamps the 
plate which holds the mouse with exposed aorta.  In the other grip, microclamps 
that hold the tip of the free edge of the plaque are mounted. A stereomicroscope 
equipped with a CCD camera was placed above the aorta to obtain a top-down 
view of the delamination process. Figure 2.1 shows a schematic of the side view 





Figure 2.1 The experimental test setup. The Bose instrument prescribes a 
displacement (actuator) and records the resulting force (load cell). The 
microclamps are attached to the actuator and grip the tip of the plaque.  A 
stereomicroscope with one CCD camera is mounted overhead to take images of 
the experiment. 
 
2.2.1.1 Mechanical testing 
The Bose Electroforce 3200 Test Instrument applied controlled 
displacement at a rate of 0.05 mm/s to detach the plaque in stages, and a 
stereomicroscope with a monochrome Q-Imaging QICAM CCD camera acquired 
images of the newly exposed area underneath the plaque at a frequency of 1 Hz.   
Consecutive cycles were run with increasing total displacement until the plaque 





2.2.1.2 Histological studies 
After complete delamination, the plaques were fixed in 10% neutral buffered 
formalin.  The plaques were embedded in paraffin and sectioned transversely at 5 
m. Masson’s trichrome staining was performed on several sections from each 
plaque.  
2.2.1.3 Data analysis 
The energy released during the delamination, ΔE, is the area under the 
load-displacement curve, shown in Figure 2.2, which is calculated from 





𝑖=1                         (2.1) 
where di and di+1 are incremental values of the displacement and li and li+1 are 
incremental values of the load. The area exposed at the plaque-IEL interface 
during one delamination cycle, ΔA, is measured using ImageJ by determining the 
area before delamination, Ai, and the area after delamination, Af. 
     ΔA = Af – Ai                                                 (2.2) 
The energy release rate, G, is a measure of adhesion strength and is 
calculated by dividing the energy released during delamination, ΔE, by the area 








The failure load of each cycle was determined by measuring the load when 
tearing initiated for each cycle, depicted in Figure 2.2. 
 
Figure 2.2 A representative image of the raw load versus displacement data. The 
area under the load-displacement curve represents the energy released during 
one delamination cycle. The failure load is the load at which tearing begins. 
 
A stiffness parameter was caclulated for each delamination cycle. First, an 
exponential trendline was fitted to the loading region of the load-displacement 
curve. The exponetential trendline is of the form  
𝐹 = 𝑎𝑒𝑏𝛿                                      (2.4) 
where F is the force or load, δ is the displacement, and a and b are 
parameters. Taking the natural logarithm of equation 4, it becomes clear that b is 
responsible for the slope of this line and a is related to the intercept. 























Therefore, b is defined as the stiffness parameter for each cycle. When the 
natural logarithm of load is plotted versus displacement, the loading portion of the 
curve becomes linear, shown in Figure 2.3. The lines with a greater slope 
correspond to the cycles with a stiffer response.  
 
Figure 2.3 A set of representative load-displacement curves from three different 
plaques (loading regions in solid lines, tearing and unloading regions in dashed 
lines) with varied stiffness parameters (top).  The natural logarithm of the load is 
plotted versus displacement for the loading region of each of these curves 
(bottom). The lines with steeper slopes correspond to the cycles with higher 
stiffness. Stiffness parameters equal 3.4, 2.4, and 1.8 for the black, medium grey, 








































A Shapiro-Wilk test was used to test the normality of the distributions of 
results. For normally distributed data, a t-test was performed to test for differences 
between the two genotypes and for non-normally distributed data, a Mann-Whitney 
nonparametric test was used to compare the median values between the ApoE-/- 
mice and the ApoE-/- Col8-/- mice. The results were considered significant if P was 
less than 0.05. 
2.2.2 Human fibrous cap adhesion strength 
The plaque adhesion strength experiments conducted in mice, described in 
section 2.2.1, were adapted to human plaque specimens. Rather than measure 
the adhesion strength at the plaque-IEL interface as in the mouse studies, the 
adhesion strength between the fibrous cap and the underlying plaque was 
measured in human carotid endarterectomy plaque specimens. 
 The current study was approved by the IRB at Greenville Health System 
on September 3, 2013 and all patients gave written informed consent. Seven fresh 
carotid endarterectomy samples were obtained at the time of surgery from two 
local hospitals (6 specimens from Greenville Health System, Greenville, SC; 1 
specimen from Palmetto Health, Columbia, SC). The carotid endarterectomy 
specimens were immersed in Belzer UW Cold Storage Solution (Bridge to Life Ltd., 
Columbia, SC, USA) immediately following excision from the patient and were kept 
cool until testing. All testing was completed within 48 hours of surgery. The 




to mechanical testing. Several specimens were large enough that multiple samples 
were prepared, resulting in a total of 11 fibrous cap delamination samples.  
At the start of an experiment, the ring-shaped plaque sample was opened 
with a longitudinal cut. At this cut edge, a scalpel was used to carefully introduce 
a small initial delamination between the fibrous cap and the underlying plaque 
tissue. The medial side of the tissue was glued to a glass plate with Dermabond 
Advanced (Ethicon Inc., Somerville, NJ, USA), a topical skin adhesive. One of the 
grips in the Bose Test Instrument was used to securely mount the glass plate, 
while the opposite grip held a micro-clamp that gripped the delaminated tab of the 
fibrous cap, as shown in Figure 2.4. 
 
Figure 2.4 Human fibrous cap delamination experimental setup. A schematic of 
the sample prepared for mechanical testing is shown on the left; an actual sample 














Controlled displacement of the microclamps was used to further delaminate 
the free edge of the fibrous cap. A charge-coupled device (CCD) camera 
(Grasshopper GRAS-50S5M, Point Grey Research, Richmond, BC, Canada) was 
placed above the tissue to capture images at a frequency of 1 Hz during the 
delamination process.  
2.2.2.1 Mechanical Testing 
 Consecutive delamination cycles at a rate of 0.05 mm/s were performed 
under displacement control. The actuator of the Bose Test Instrument prescribes 
a displacement for the microclamps which grip the plaque, and the resulting load 
is recorded by the grips that mount the glass plate. The cyclic loading-
delamination-unloading cycles are performed until complete delamination of the 
fibrous cap is achieved.  
2.2.2.2 Histological Studies 
 After delamination, each portion of the tissue (delaminated fibrous cap, 
underlying plaque and media) was fixed in 4% paraformaldehyde in 0.1 M 
phosphate buffer, pH 7.4. The samples were embedded in paraffin and sectioned 
transversely at 5 μm.  
2.2.2.3 Data Analysis 
 The analysis of the results obtained in this section was performed identically 






2.3.1 Mouse plaque adhesion strength is unaffected by collagen VIII deficiency 
Five plaques from ApoE-/- mice were tested in 17 peeling cycles, resulting 
in an average local energy release rate of 15.4 J/m2.  Twenty-two peeling cycles 
were obtained from nine plaques from ApoE-/- Col8-/- mice, with an average local 
energy release rate of 16.2 J/m2.  Figure 2.5 shows that the local energy release 
rates between ApoE-/- and ApoE-/- Col8-/- plaques have similar distributions, though 
the maximum energy release rate for ApoE-/- Col8-/- mice is higher than that in 
ApoE-/- mice.  
 
Figure 2.5 A box and whiskers plot shows that the distribution of local energy 
release rate (G) values is similar in both mouse genotypes. 
 
Figure 2.6 shows that the histograms for energy release rate distribution are 






































and both distributions are positively skewed. A statistical summary of the 
distributions is shown in Table 2.1. Based on the results of the Shapiro-Wilk test, 
the distribution of plaque energy release rate values is non-normal (p < 0.01) in 
both ApoE-/- and ApoE-/- Col8-/- mice. A Mann-Whitney test reveals that there is no 
significant difference between the median energy release rates of the two 
populations of transgenic mice (P-value = 0.82). The stiffness parameter 
(calculated from equation 2.4) and failure load values for both genotypes were 
normally distributed.  A t-test shows that stiffness is reduced in ApoE-/- Col8-/- mice 
compared to ApoE-/- mice (P < 0.05). The failure load values were not significantly 
different between the two genotypes.  
 
Figure 2.6 Distribution of local energy release rate, G, for ApoE-/- and ApoE-/- Col8-
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Table 2.1 Statistical parameters for local energy release rate, stiffness parameter, 



















Mean 15.4 16.4 1.83 1.47 6.37 5.75 
Standard 
Deviation 
11.7 18.8 0.72 0.37 2.86 2.63 
First 
Quartile 
8.03 7.51 1.27 1.23 5.10 3.46 
Median 10.9 10.1 1.44 1.49 5.98 4.85 
Third 
Quartile 
18.0 15.0 2.41 1.71 8.53 7.72 
Kurtosis 0.95 14.0 -1.06 0.00 0.69 -1.25 
Skew 1.40 3.54 0.61 0.12 0.88 0.16 
 
The histology performed on the delaminated tissue verifies that 
delamination occurred between the atherosclerotic plaque and the IEL, rather than 
within the media or between the media and the adventitia. Representative images 
of plaque alone and plaque with media are shown in Figure 2.7. Histology was 
performed on every delaminated specimen to confirm the plane of delamination.  
Specimens which delaminated outside the plaque-IEL interface were not included 







Figure 2.7 Trichrome staining on sections of peeled plaque specimens from      
ApoE-/- mice verifies the plane of delamination. Representative histological images 
showing plaque only, confirming delamination at the plane of interest, the plaque-
IEL interface (left) and section for comparison showing plaque attached to media, 
showing that in this case the delamination did not occur in the plane of interest 
(right). Scale bar = 100 m. 
 
2.3.3 Human atherosclerotic fibrous cap adhesion strength results 
Eleven fibrous cap delamination experiments resulted in a total of 83 
delamination cycles and an average energy release rate of 343 J/m2. There is high 
variability in the local energy release rates both within one plaque sample and 
between plaques from different patients, as shown in Figure 2.8. The histogram of 
energy release rate values in Figure 2.9 shows a positively skewed distribution 
with a frequency peak around 200 J/m2.  
Table 2.2 summarizes the key statistical parameters in the human plaque 
adhesion strength data set. The energy release rate measurements have a 
standard deviation approximately equal to the mean. Local energy release rate, 






Figure 2.8 A box and whiskers plot for local energy release rate by patient. Patients 
I, II, IV, and V each provided two fibrous cap delamination samples. 
 
 
Figure 2.9 Histogram of local energy release rates during fibrous cap peeling in 





















































Table 2.2 Statistical parameters for local energy release rate, stiffness parameter, 
and failure load values for human fibrous caps 
 
 Trichrome staining on delaminated fibrous caps was analyzed to confirm 
that delamination occurred between the fibrous cap and the underlying plaque. A 
representative image of both the fibrous cap and the underlying plaque is shown 
in Figure 2.10.  
 
Figure 2.10 A representative image of delaminated human fibrous cap (top) and 
underlying plaque and media (bottom) stained with Masson’s Trichrome. Blue = 








Mean 343 2.13 360 
Standard 
Deviation 
338 0.90 276 
First Quartile 123 1.66 148 
Median 221 2.00 262 
Third Quartile 386 2.38 504 
Kurtosis 3.9 19.6 1.5 





2.4.1 Mouse plaque adhesion strength is unaffected by collagen VIII 
The adhesion strength between the atherosclerotic plaque and IEL as well 
as the load at which tearing initiates are unchanged between ApoE-/- and ApoE-/-
Col8-/- mice. However, the plaques in ApoE-/- Col8-/- mice are less stiff than those 
in ApoE-/- mice. Stiffness is a structural property that depends on both material 
properties and specimen geometry, in this case the thickness and width of the 
plaque. We have not isolated the influence of material properties and geometry on 
the stiffness parameter measurements. However, Lopes et al. have previously 
shown that plaque size and burden of atherosclerosis are similar between ApoE-/- 
and ApoE-/- Col8-/- mice [42].  While these results suggest that material properties 
may solely be responsible for the change in stiffness, further studies are needed 
to confirm this.  Lower plaque stiffness in the ApoE-/- Col8-/- mice is consistent with 
previous observations of impaired fibrous cap formation in this genotype [42]. 
The local energy release rate for delamination of atherosclerotic lesions in 
ApoE-/- mice after 8 months on diet has previously been reported with average 
values of 19.2 J/m2 and 24.5 J/m2 [36], [37].  The current study finds an average 
value for the local energy release rate of plaque delamination in ApoE-/- mice after 
6 months on diet to be 15.4 J/m2. In general, our results agree with previous 
studies, however it is important to note the difference in time points. While there is 




2.11), a Mann-Whitney nonparametric test confirms that there is not a statistically 
significant difference in the energy release rate of these two populations. 
 
Figure 2.11 The effect of time on western diet on plaque adhesion strength in 
ApoE-/- mice. Data for the adhesion strength from ApoE -/- mice on western diet for 
8 months was obtained from [37]. Error bars represent standard deviation. 
 
Previous studies have shown that there is a positive correlation between 
local energy release rate and total collagen content as measured by Picrosirius 
Red staining [37].  Our study shows that the energy release rate is unaffected by 
the absence of type VIII collagen and suggests that other types of collagen may 
be responsible for the differences in adhesion strength previously reported. We 
have shown that the ApoE-/- Col8-/- plaques are less stiff than the ApoE-/- plaques, 
which may be caused by the lack of type VIII collagen or by impaired migration of 




































This study shows that the absence of type VIII collagen does not reduce 
plaque adhesion strength and thus does not reduce the mechanical likelihood of 
plaque failure by delamination at the plaque shoulder. However, these studies 
have not ruled out the possibility that plaques in ApoE-/- Col8-/- mice may be more 
susceptible to failure by tensile rupture of the fibrous cap. 
2.4.2 Comparison between human and mouse results 
 The current study shows that energy release rate and failure load are one 
to two orders of magnitude higher in human fibrous cap delamination than in 
mouse aortic plaque delamination. While this finding may indicate structural 
differences in tissue types between species, it is also important to note several 
differences in methodology in the two sets of experiments. First, plaque adhesion 
strength is measured in the longitudinal direction at the plaque-IEL interface in 
mice, while it is measured in the circumferential direction between the fibrous cap 
and the underlying lipid core in human tissue. Logistically, the diameter of the 
mouse aorta is too small to readily test circumferential plaque adhesion strength. 
Additionally, mouse plaques generally do not have distinct and thickened fibrous 
caps as do human atherosclerotic plaques. Human plaques are highly 
heterogeneous, and many plaques contain a very weak lipid core that can not 
withstand the loads applied during experimental delamination.  In these instances, 
the lipid core disintegrates rather than delaminating cleanly from the IEL.  
Other studies investigating delamination strength in human arteries have 




studies investigated delamination within the layers of an artery rather than plaque 
fibrous cap delamination, which could explain the higher results obtained in our 
study. 
While the human atherosclerotic plaques are much stronger than those 
found in mice, the plaque adhesion strength data sets are qualitatively similar, in 
terms of having positively skewed distributions of energy release rate and standard 
deviations which are approximately equal to the means. While the quantitative 
values of the mouse plaque adhesion strength may not be representative of human 
samples, many of the qualitative behaviors observed during plaque delamination 
are similar in both species.  
2.5 Future Work 
This study has examined plaque adhesion strength in both mouse and 
human tissue; however, the microscopic mechanism for failure at this interface is 
still unknown. Likely potential determinants of plaque adhesion strength are 
adhesive proteins binding the two layers or bridging fibers extending between the 
two layers. Thus, failure may involve either de-cohesion of protein-protein 
interactions, fiber breakage, or both.  Both of these failure mechanisms should be 
investigated further. 
In addition to plaque adhesion strength, other plaque rupture mechanisms 
should be investigated to assess plaque stability, such as tensile rupture of the 
fibrous cap. Both adhesive and tensile failure can potentially lead to clinical events, 




providing mechanical properties for computational simulations of atherosclerotic 
plaque behavior. 
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3.1 Introduction  
Atherosclerotic plaque failure is one of the leading causes of myocardial 
infarction. There are at least two potential failure mechanisms for atherosclerotic 
plaques.  The first involves tensile rupture of the fibrous cap and the second, which 
is prominent during angioplasty, involves plaque delamination from the internal 
elastic lamina (IEL) at the plaque shoulder.  During balloon angioplasty, a catheter 
is inserted into the blood vessel and a small balloon is inflated at the lesion.  The 
goal is to flatten the plaque and to increase the lumen area; however, in some 
cases this results in intimal dissection at the plaque shoulder.  The resulting arterial 
damage is commonly treated with the implantation of a stent over the dissected 
tissue to hold the intimal and medial surfaces together and to recreate a smooth 
lumen [25], [26], [59].  
Identifying the matrix proteins responsible for adhesion between the plaque 
and the IEL may provide insight into the delamination mechanism for 
atherosclerotic plaque failure at the shoulder. Wang et al. have used plaque 
peeling experiments to determine the local energy release rate, G, a measure of 
adhesive strength between the plaque and the IEL [36], [37]. A significant positive 
correlation was found between local collagen content in the plaque and adhesion 
strength between the plaque and the IEL, suggesting that collagen is an important 
determinant of plaque adhesion strength [37].  
Tsamis et al. have shown that during vascular remodeling of the 




radially oriented [60]. Vascular remodeling also occurs due to atherosclerotic 
plaque formation and may result in a similar reorganization of fibers.  If radially 
oriented fibers are present at the plaque-IEL interface, they may be responsible 
for the adhesion strength at this interface. Previous studies in our lab have shown 
that IEL degradation increases adhesion strength between the plaque and the IEL, 
raising the possibility that fiber bridges extending between the intima and media 
contribute to interfacial toughness [37].  The composition of these potential bridges 
is unknown, though they likely form from proteins found in the surrounding ECM. 
Contributions to adhesion strength may also come from adhesive proteins that link 
ECM components together. Potential failure mechanisms at the plaque-IEL 
interface include a) fiber breakage, b) fiber pull out or decohesion from the 
surrounding ECM, c) adhesive failure mediated by glycoproteins, or d) any 
combination of the three. 
In this study, we seek to characterize the ECM composition at the mouse 
plaque-IEL interface and to investigate the potential contribution of specific matrix 
constituents to interfacial adhesion strength. The matrix proteins selected for 
investigation are collagen I, collagen IV, fibrillin-1, fibronectin, and osteopontin. 
These proteins were chosen to include both adhesive glycoproteins and fibrillar 
ECM proteins known to be present within atherosclerotic plaques.  In addition, we 
used biomechanical methods to investigate the adhesive/cohesive strength of thin 
films of purified protein to determine how strongly these matrix proteins adhere to 




Based on the results in Wang et al. [37], collagen is a potential contributor 
to plaque adhesion strength. Collagen I, a fibrillar collagen, is the most abundant 
protein in vascular tissue.  Collagen IV is a basement membrane protein that forms 
structural networks or scaffolds which interact with proteoglycans [61], [62] and 
cells [63], [64] and. In healthy tissue, collagen IV is found at the intimal-medial 
border, and we hypothesize that collagen IV will also be present at the plaque-IEL 
interface in the atherosclerotic diseased state.  
Fibrillin-1 is a key component of microfibrils, which provide a scaffold for 
elastic fiber formation. Though microfibrils are primarily associated with mature 
elastic fibers [8], they are found in the absence of elastin in ciliary zonula of the 
eye and superficial regions of the skin [9]. In the absence of elastin, microfibrils 
contribute to the structural integrity of the tissue [10] and exhibit nonlinear material 
behavior [65]. Microfibrils frequently interact with the basement membrane via 
perlecan [66] and can adhere to cells [67]. Additionally, microfibrils have been 
shown to link endothelial cells to the internal elastic lamina in developing mouse 
aorta [11], [12]. 
Fibronectin and osteopontin may contribute to the strength of the plaque-
IEL interface through adhesive interactions with other ECM components. 
Fibronectin has a multidomain structure which enables binding to cell surfaces as 
well as to other extracellular matrix molecules, such as collagen, and 
proteoglycans [13], [68], [69]. Osteopontin is a secreted adhesive protein, 
commonly expressed in inflammatory and auto-immune diseases, that binds to 




Osteopontin may be an important adhesive molecule at the plaque-IEL interface 
because of its ability to bind directly to fibronectin [71] and collagen [72]. Therefore, 
both fibronectin and osteopontin may be structural links between ECM 
components and cells at the plaque-IEL interface. 
In situ blotting, or histoblotting, has been used previously to transfer protein 
directly from frozen or fixed tissue sections to nitrocellulose or polyvinylidene 
difluoride (PVDF) membranes and stain with histochemical or immunological 
methods to detect specific proteins [73], [74]. This study builds on those techniques 
by blotting fresh, unsectioned tissue on PVDF membranes along with a series of 
protein standards to allow for approximate protein quantitation. More specifically, 
we investigate the protein concentration at the plaque-IEL interface by blotting 
fresh atherosclerotic plaques peeled from the IEL onto PVDF membranes. 
Khayer Dastjerdi et al. developed an elegant technique, the rigid double 
cantilever beam (RDCB) test, for measuring the fracture toughness during 
cohesive failure of soft biological adhesives [75]. This RDCB technique also allows 
for direct determination of the full traction-separation function. The RDCB 
technique is slightly modified in this study, by adding a layer of decellularized aorta 
between each beam and the protein layer. Using this modified technique, the 
fracture toughness of isolated proteins can be determined for failure at the 
interface between the protein layer and the matrix or within the protein layer itself.  
Combining these two techniques allows for an interesting study on the 




we have investigated the contributions of adhesive proteins to the delamination 
strength, or adhesive strength, of the plaque-IEL interface. However, this 
technique can be applied to a broad range of biological materials. 
3.2 Materials and Methods 
3.2.1 Immunohistochemistry 
All procedures involving vertebrate animals were approved by the USC 
Institutional Animal Care and Use Committee. Apolipoprotein E knockout (ApoE-/) 
mice were put on a Western (42 kcal% fat, Harlan-Teklad, Indianapolis, IN) diet for 
eight months to develop advanced atherosclerotic plaques in the descending 
aorta. After eight months, two mice were sacrificed by CO2 asphyxiation and 
perfused with heparinized saline for five minutes. The aorta from each mouse was 
harvested and fixed in neutral-buffered formalin, embedded in paraffin, and 
sectioned transversely at five μm.  
Immunohistochemistry (IHC) was used to determine the presence and 
distribution of collagen I, collagen IV, fibrillin-1, osteopontin, and fibronectin in 
sections of the aortic wall with atherosclerotic lesions. Collagen I, collagen IV, 
fibrillin-1, fibronectin and osteopontin were detected with the following antibodies, 
respectively: rabbit anti-collagen I polyclonal antibody (1:20 dilution, Calbiochem, 
San Diego, CA), rabbit anti-collagen IV polyclonal antibody (1:20 dilution, Abcam, 
Cambridge, MA), rabbit anti-fibrillin-1 polyclonal antibody (1:20 dilution, Abcam, 
Cambridge, MA), rabbit anti-fibronectin antibody (1:100 dilution, Novus Biologicals, 




Cambridge, MA). Donkey anti-rabbit rhodamine red X (RRX)–labeled secondary 
antibodies (Jackson Immuno Research Laboratories, Inc., West Grove, PA) were 
used to detect collagen I, fibronectin, and osteopontin. For collagen IV and fibrillin-
1, biotin-conjugated donkey anti-rabbit IgG (Jackson Immuno Research 
Laboratories, Inc., West Grove, PA) was used as a secondary antibody, followed 
by RRX-labelled streptavidin (Jackson Immuno Research Laboratories, Inc., West 
Grove, PA). Lastly, the tissue sections were counterstained with Hoechst 33342 
(1:10,000 dilution, Thermo Fisher Scientific, Waltham, MA). A Zeiss LSM 510 
confocal microscope was used to capture images at 40X and 63X magnification. 
3.2.2 Semi-quantitative plaque immunoblotting 
A novel plaque immunoblotting technique was used to identify and quantify 
adhesive proteins present locally at the plaque-IEL interface. Five ApoE-/- mice 
were sacrificed by CO2 asphyxiation and perfused with heparinized saline for five 
minutes. The descending aorta was opened longitudinally to visualize the 
atherosclerotic lesions. Forceps were used to make an initial flaw at one edge of 
the plaque-IEL interface. The free edge of the plaque was gripped and gently 
peeled from the aortic wall. A total of 23 plaques from 5 mice were used in these 
experiments. The plaque was briefly blotted three times in sequence onto adjacent 
areas of a PVDF membrane (the IEL interface side contacting the membrane) that 
had been rinsed with methanol and transfer buffer (25 mM Tris, 192 mM glycine, 
20% (v/v) methanol).  A set of protein standards (rat tail collagen I, EMD Millipore 
Corporation, Billerica, MA; mouse collagen IV, BD Biosciences, Bedford, MA; 




fibronectin, EMD Millipore Corporation, Billerica, MA; human recombinant 
osteopontin, BioVision Inc., Milpitas, CA) at known concentrations was applied to 
the membrane to allow for approximate quantitation of the protein transferred from 
the plaque-IEL interface.  
After the membrane had absorbed all protein, it was rinsed in Tris-buffered 
saline (TBS), pH 7.4, and placed in 1% bovine serum albumin (Sigma-Aldrich, St. 
Louis, MO, USA) in TBS for 1 hour. The membrane was then incubated with the 
appropriate primary antibodies, see section 2.1, at modified dilutions (1:500, 
1:3750, 1:1000, 1;1000, and 1:1000 for collagen I, collagen IV, fibrillin-1, 
fibronectin, and osteopontin, respectively) for 1 hour, followed by biotinylated 
donkey anti-rabbit IgG (1:1000 dilution, Jackson Immuno Research Laboratories 
Inc., West Grove, PA) for 1 hour and IR 800 labelled streptavidin (1:1000 dilution, 
LI-COR Biosciences, Lincoln, NE) for 45 minutes. The membranes were imaged 
using an Odyssey CLx Imaging System (LI-COR Biosciences, Lincoln, NE) and 
analyzed quantitatively using ImageJ (version 1.50c4, National Institutes of Health, 
USA).  
The first step in determining the ex vivo protein concentration is to create a 
standard curve using samples of known protein concentrations. On some of the 
plaque blots, the protein standards at the higher concentrations spread and 
created a larger area of lower signal. To correct for this effect, the total signal was 
calculated by measuring average pixel intensity multiplied by the area of the 
protein dot. An adjusted average pixel intensity was calculated by dividing the total 




intensity can be viewed as the average pixel intensity, if no spreading had 
occurred, and was used in all subsequent calculations. An adjusted average pixel 
intensity was calculated for each spot, whether or not obvious spreading had 
occurred.  
The “area concentration” of each standard spot was determined by dividing 
the known mass of protein added to the membrane (volume of standard x standard 
concentration) by the area of the smallest standard dot (the same area used to 
determine the adjusted average pixel intensity). The area concentration and the 
adjusted average pixel intensity were plotted after a logarithmic transformation of 
each variable, and a linear regression was performed for each set of standard 
proteins. The ex vivo concentration was calculated using the linear regression to 
determine the logarithmic transformed concentration, which was then converted to 
true concentration. In each case, the ex vivo area concentration was calculated 
based on the average pixel intensity from the first of the three adjacent plaque blot 
images on the PVDF membrane. 
In order to confirm proteins were only transferring from the plaque-IEL 
interface, plaque blots were compared alongside tissue blots from within the media 
of the aorta and stained with anti-actin smooth muscle antibody (1:500 dilution, 
Thermo Fisher Scientific, Waltham, MA). Smooth muscle cells (SMCs) are present 
much higher levels in the media of the artery or within the fibrous cap of the plaque, 
but are relatively sparse at the plaque-IEL interface. Therefore, the signal should 




only transferring protein from the interface of interest and no contamination from 
other tissue surfaces is occurring.  
This method is described as semi-quantitative because all protein at the 
plaque-IEL interface does not necessarily transfer to the PVDF membrane in one 
blot. Each plaque was blotted onto a single PVDF membrane three times, resulting 
in three adjacent images. While the signal is visually similar for each plaque blot, 
the calculated concentrations are generally not within 10%.  The collagen I 
concentration is generally highest in the third plaque blot while the collagen IV 
concentration is generally the lowest in the third blot. This suggests that protein 
transfer is beginning to occur in the body of the plaque at these later blots (collagen 
I is more abundant in the body of the plaque and collagen IV is less abundant 
there). For this reason, only the first plaque blot is used for quantification. These 
results also suggest that the majority of the protein from the plaque-IEL interface 
transfers to the PVDF membrane within two blots. While true quantification cannot 
be achieved, this technique is useful to investigate relative abundance among 
several interfacial matrix proteins.  
3.2.3 Mechanical testing of purified protein films using rigid double cantilever beam 
experiments 
Rigid double cantilever beam (RDCB) experiments to measure the 
adhesive/cohesive strength of purified protein films were adapted from Khayer 
Dastjerdi et al. [75]. To simulate dissection at the interface between arterial tissue 




decellularized porcine aorta prior to RDCB testing. Porcine aortas were obtained 
from a local slaughterhouse (Caughman’s Meat Plant, Lexington, SC) and 
decellularized in 0.1% sodium dodecyl sulfate (SDS) for 48 hours at room 
temperature with gentle shaking. The tissue was placed in fresh 0.1% SDS every 
24 hours.  
After decellularization, the aorta was cleaned of fat and cut into a series of 
segments 5 mm wide by 25 mm long. The adventitial side of each segment was 
glued onto a glass beam of the same size using Dermabond (Ethicon Inc., 
Somerville, NJ, USA) (a topical skin adhesive). The glass beams were cut from 
microscope slides using a carbide-tipped glass cutter and a custom framing device 
to ensure uniform dimensions. At one end of the beam, a glass coverslip (0.17 mm 
thick) was placed on the decellularized aorta to control the thickness and the initial 
crack length of the protein film. Ten μL of protein at specified concentration (0.125, 
0.25, 0.5, or 1 μg/μL) was added to the opposite end of the beam. An identical 
glass beam bonded to decellularized aorta was placed on top of the first beam and 
protein film to create a “sandwich” (see Figure 3.1). The beams and protein film 
were incubated overnight in a humid chamber at 4C. Wooden tabs containing 
2.25 mm diameter through-thickness holes were attached to each glass beam with 
standard superglue.  
The beams were mounted into a Bose 3200 Test Instrument (Bose Corp, 
Framingham, MA) by placing 1.25 mm pins through the holes in the wooden tabs, 
as shown in Figure 1. The displacement of the pins was initially increased such 




displacement at a rate of 0.01 mm/s was applied to the sample until complete 
failure occurred.  Load and displacement were recorded by the Bose 3200 
software at a frequency of at least 2 Hz. 
 
Figure 3.1 RDCB experimental setup. 
 
3.2.3.1 Theory of Adhesion Strength Calculations 
Based on the theory presented by Khayer Dastjerdi et al. [75], [76], the 
exact traction-separation curve for an adhesive interface can be calculated from 











 Where t is the traction, δ is the separation at the leading edge of the protein 
layer, L is the length of the beams, B is the width of the beams, a0 is the initial 
crack length, F is the instantaneous force, and Δ is the opening between the two 




 ∆                                      (3.2) 
The traction-separation curve was plotted until the traction reaches zero, at 
which point maximum separation distance has been reached. The energy release 
rate, G, was determined by measuring the area under the traction-separation curve 
using the trapezoidal rule, 
𝐺 = ∑ (
𝑡𝑖+𝑡𝑖+1
2
) ∗ (𝛿𝑖+1 − 𝛿𝑖)
∞
𝑖=0                          (3.3) 
where ti and ti+1 are sequential traction values, and δi and δi+1 are the 
corresponding sequential separation values. 
To combine the results from the RDCB experiments with those collected in 
Section 3.2.2, the equivalent volumetric concentration was determined for each of 
the ex vivo protein concentrations measured by plaque immunoblotting.  The 
equivalent volumetric concentration was determined by creating a standard curve 







3.2.4 Scanning electron microscopy (SEM) of partially delaminated plaques 
Scanning electron microscopy (SEM) was used to examine the surface of 
the plaque-IEL interface. A partially delaminated plaque was prepared for SEM 
imaging with standard techniques for SEM images. In brief, the samples were fixed 
in 4% glutaraldehyde overnight, critical point dried, and sputter coated with gold. 
Images were taken with a JEOL 6300V scanning electron microscope (JEOL USA, 
Peabody, MA) at 4000X magnification. 
3.2.5 Statistical Analysis 
For plaque immunoblotting studies, we quantified results only from 
experiments in which the protein standard curve had an R2 value greater than 0.8 
and which did not require more than 10% extrapolation beyond the range of 
standard values to determine the concentration of unknowns (i.e., protein area 
concentrations of individual plaques). One-way ANOVA was used to compare 




Representative IHC results for each protein are shown in Figure 3.2. In each 
case, the green signal represents tissue autofluorescence, the red signal is the 
protein of interest and the blue signal corresponds to cell nuclei. Collagen I is 




the adventitia. Collagen IV is closely associated with portions of IEL. Collagen IV 
is strongly associated with one section of the IEL and notably absent from an 
adjacent segment of IEL. Fibrillin-1 is present at the plaque-IEL interface, though 
to a lesser extent than either collagen I or collagen IV, and within the media of the 
artery. There are several bright spots of signal within the body of the plaque for 
fibrillin-1 staining. These spots may be microfibrils oriented perpendicular to the 
plane of section. Fibronectin is present along the plaque-IEL interface, within the 
media of the artery, and near the luminal plaque edge, though absent from the 
plaque core. Conversely, osteopontin is most strongly associated with the plaque 
core and the underlying plaque-IEL interface.  
 
Figure 3.2 Representative Immunohistochemistry results for each matrix protein at 
40X magnification (top row) and 63X magnification (bottom row). All scale bars 
represent 20 μm. Arrows point to protein at the plaque-IEL interface, circles denote 
protein in the body of the plaque, stars show protein within the media, and 






3.3.2 Semi-quantitative plaque immunoblotting 
Representative results from the plaque immunoblotting experiments are 
shown in Figure 3.3.  In total, we obtained three measurements of collagen I 
interfacial concentration, three measurements of collagen IV concentration, two 
measurements each of fibrillin-1 and fibronectin concentration, and no 
measurements for osteopontin. Osteopontin was detected at the plaque-IEL 
interface using the plaque immunoblotting technique; however, the protein 
standard curves were not of sufficiently high quality to quantitate the ex vivo 
concentration. The standard curves were linear at low protein concentrations, but 
appeared to saturate at higher concentrations in the range of the ex vivo 
concentration. The quantitative results (Figure 3.4, Table 3.1) show that collagen I 
and collagen IV are slightly more abundant at the plaque-IEL interface than fibrillin-
1 and fibronectin; however, one-way ANOVA demonstrated no significant 
differences between the average concentrations of each protein. The standard 
deviation in each case is approximately equal to the mean, a trend which was also 
observed with the plaque adhesion strength results [36], [37]. The variation in 
measured interfacial protein concentrations is consistent with the observed 
variability in plaque adhesion strength measurements. 
Comparison of plaque and media blots stained with anti-smooth muscle 
actin show that the signal is greatly reduced in the plaque compared to the media 
(Figure 3.5). These results support the notion that protein transfer is not occurring 
from the media or from the fibrous cap, instead protein is only transferring from the 





Figure 3.3 Representative plaque immunoblotting results showing standards with 
no spreading at high standard concentration (left) and standards which have 
spread at the two highest standard concentrations (middle). A schematic is shown 
(right). Insets show plaque blots. 
 
Figure 3.4 Summary of ex vivo protein concentrations at the plaque-IEL interface 





























Proteinn = 3 n = 3







Table 3.1 Summary of ex vivo protein concentrations at the plaque-IEL interface 
quantified by immunoblotting 
 
 
Figure 3.5 A representative blot stained with anti-SMA in the plaque and in the 















Collagen I 0.020 0.027 0.92 - 
Collagen I 0.003 0.004 0.99 -0.39 
Collagen I 0.049 0.073 0.97 - 
Average  0.024 ± 0.023 0.035 ± 0.035 - - 
Collagen IV 0.001 0.002 0.92 - 
Collagen IV 0.007 0.021 0.92 - 
Collagen IV 0.068 0.088 0.87 - 
Average  0.025 ± 0.037 0.037 ± 0.045 - - 
Fibrillin-1 0.024 0.030 0.98 - 
Fibrillin-1 0.010 0.012 0.97 - 
Average  0.017 ± 0.009 0.021 ± 0.013 - - 
Fibronectin 0.002 0.003 0.81 -4.43 
Fibronectin 0.030 0.057 0.92 - 






3.3.3 Mechanical testing using RDCB experiments 
RDCB experiments were performed using collagen IV protein films at 
several concentrations sandwiched between strips of decellularized porcine aorta. 
A representative load-displacement curve and traction-separation curve for 
collagen IV at each protein concentration is shown in Figure 3.6. The maximum 
load is generally reduced with deceasing protein concentration. Similarly, the 
maximum traction decreases with decreasing protein concentration while the 
maximum separation is relatively unchanged. Table 3.2 summarizes the key 
results from the RDCB experiments.  
The results of RDCB experiments summarized in Figure 3.7 show that the 
adhesion strength, or energy release rate, of thin protein films increases 
exponentially with collagen IV concentration. Some of the variability in energy 
release rate may be explained by the difference in porcine tissue samples from 
different subjects. At the expected ex vivo equivalent concentration estimated from 
the plaque immunoblotting experiments (0.037 μg/μL), the corresponding energy 
release rate for collagen IV (0.62 J/m2) is approximately one order of magnitude 
lower than the  published experimental measurements of mouse plaque-IEL 
adhesion strength (19.3 J/m2; 24.5 J/m2) [36], [37]. This discrepancy suggests that 
while collagen IV is relatively abundant at the plaque-IEL interface, it is not a key 








Figure 3.6 Representative load-displacement (top) and resulting traction-







































































Collagen IV 1.000 25.1 0.82 9.98 
Collagen IV 0.500 7.28 0.83 2.58 
Collagen IV 0.250 3.58 0.51 0.66 
Collagen IV 0.125 3.75 0.86 1.22 
 
 
Figure 3.7 RDCB results for adhesion strength of thin collagen IV films compared 
to in situ adhesion strength of mouse atherosclerotic plaque (from [37]). Error bars 
represent standard deviation. 
 
3.3.4 Scanning Electron Microscopy of partially delaminated atherosclerotic 
plaques 
The results from SEM of partially delaminated atherosclerotic plaques show 










































fibers may be key structural components of the plaque-IEL interface. Radially 
oriented bridging fibers between the plaque and the IEL will increase adhesion 
strength and resist failure between these two layers. The number, diameter, and 
orientation of these fibers may affect the overall adhesion strength at the plaque-
IEL interface. 
 
Figure 3.8 Scanning electron microscopy (SEM) of partially delaminated mouse 
plaque shows bridging fibers (arrows) exist at the plaque-IEL interface. Scale bar 
represents 1 m. 
3.4 Discussion 
The results from immunohistochemistry and plaque immunoblotting studies 
show good agreement. Collagen I is clearly present at the plaque-IEL interface, 
confirmed by both IHC and plaque immunoblotting results. IHC shows that 
collagen IV is clearly associated with the IEL, though its distribution appears to be 




entire IEL surface could explain the large standard deviation in the plaque 
immunoblotting results. While both fibrillin-1 and fibronectin appear to be present 
at the plaque-IEL interface by IHC, the staining intensity is lower than for collagen 
I or collagen IV. These results are mimicked in the plaque immunoblotting results, 
where fibrillin-1 and fibronectin are slightly less abundant than collagen I and 
collagen IV. The concentration of osteopontin was not quantified; however, both 
IHC and plaque immunoblotting (data not shown) confirm that osteopontin is 
present at the plaque-IEL interface. 
Examining the results from the RDCB experiments can provide insight into 
the mechanism of failure at the plaque-IEL interface by providing bounds on the 
forces required to separate surfaces adhered by a thin protein film. We 
hypothesize two potential sources of adhesion strength or tearing toughness at the 
interface: 1) bridging fibers that extend between tissue layers and/or 2) adhesive 
matrix proteins at the interface. The RDCB experiments can measure the 
mechanical toughness of a thin film of adhesive protein. The results from the 
RDCB experiments in this study show that collagen IV is not a likely key constituent 
determining adhesive strength at the plaque-IEL interface. When extrapolating the 
results of the RDCB experiments to the ex vivo protein concentration estimated by 
immunoblotting, we find that collagen IV exhibits an adhesive strength 
approximately one order of magnitude below previously measured in situ plaque 
adhesion strengths. Even at concentrations much higher than those found ex vivo, 




results. These results clearly indicate that collagen IV is not likely to be responsible 
for the mechanical strength at the plaque-IEL interface.  
RDCB experiments were also performed on thin films of fibronectin which 
resulted in a limited number of results due to the weak mechanical strength of 
these films (data not shown). The RDCB experiments measured the adhesive 
properties of human plasma fibronectin rather than cellular fibronectin. Both forms 
of fibronectin are encoded by a single gene and alternatively spliced to form the 
different variants. Cellular fibronectin is produced by fibroblasts, endothelial cells, 
and smooth muscle cells and is present as insoluble fibrils in the ECM, while 
plasma fibronectin is produced only by hepatocytes and is soluble in blood plasma 
and body fluids [77]–[81]. Several studies show that plasma fibronectin exhibits 
adhesive properties, specifically to  cells [77], collagen [78], [82], and 
glycosaminoglycans [79], [83].  Additionally, plasma fibronectin can be 
incorporated into the vascular wall and form fibrils alongside cellular fibronectin 
[80], [81]. While plasma fibronectin may exhibit some adhesive properties, the 
RDCB results suggest that the adhesive strength is far weaker than collagen IV 
and therefore unlikely to contribute to the strength of the plaque-IEL interface. The 
fibrillar form of fibronectin should be further investigated as a potential contributor 
to adhesion strength at the plaque-IEL interface.  
Other structural proteins that match the mechanical adhesive strength 
properties measured in situ must be localized to the plaque-IEL interface. Collagen 
I, fibrillin-1, and fibronectin are potential candidates for the components of the 




proteins are present at the appropriate location. However, measuring the 
mechanical strength of fibers is fundamentally different than measuring the 
mechanical strength of adhesive proteins. RDCB experiments are not appropriate 
to directly test the mechanical strength of fibrillar proteins. First, the in vivo 
orientation of fibers will significantly affect their contribution to interfacial 
toughness. We did not make an effort to control fiber orientation in the thin films 
used for this study. Additionally, the number and thickness of the fibers or fiber 
bundles will also affect the adhesive strength of the interfacial layer. Future 
examination of bridging fibers in situ at the plaque-IEL interface is necessary. 
Atomic force microscopy (AFM) has been used to measure the mechanical 
properties of single collagen or elastic fibers [84]–[86]; however, computational 
simulations would be necessary to estimate an energy release rate from these 
measurements. An alternative technique that has been used to determine the 
energy release rate during fiber pull-out of individual carbon nanotubes from epoxy 
composites, using a combined micromechanical tester and SEM [87], may offer 
potential for determining mechanical properties of fibers at the plaque-IEL 
interface.  
The methodology used in this study represents a novel technique that can 
be applied to determine the proteins responsible for the adhesive strength of other 
biological interfaces, such as those between layers of an artery or between 
cartilage and bone. The plaque immunoblotting technique can be applied to 
estimate protein concentrations at other biological interfaces and surfaces. Though 




al., the combination of this technique with plaque immunoblotting constitutes a 
novel methodology that can be used to determine the adhesive strength 
contribution of individual proteins or protein mixtures at biological interfaces. 
The results from this study include a preliminary candidate group of 
proteins, and examining additional adhesive matrix proteins is relevant future work. 
Most importantly, determining the composition of the bridging fibers and measuring 
their breaking strength will provide great insight into the failure mechanism at the 
plaque-IEL interface.  Additionally, plaque adhesion strength may result from the 
synergistic interaction of several proteins forming matrix architectures that have 
emergent mechanical properties. To gain additional insight into failure 
mechanisms at the plaque-IEL interface, it may be necessary to evaluate 
cohesive/adhesive properties of protein mixtures as well as bridging fiber pull-out 
strength from native vascular ECM. 
3.5 Conclusions 
This study describes a novel technique that has been used to investigate 
contributions of adhesive matrix proteins to the strength of the plaque-IEL 
interface. We show that collagen I, collagen IV, fibrillin-1, fibronectin, and 
osteopontin are all present at the plaque-IEL interface. Semi-quantitative plaque 
immunoblotting shows that collagen I and collagen IV are present at slightly higher 
concentrations than fibrillin-1 and fibronectin at the plaque-IEL interface, though 
these differences do no reach statistical significance. RDCB experiments show 




plaque-IEL interface. SEM images of a partially delaminated plaque show bridging 
fibers exist at the plaque-IEL interface. These fibers, potentially composted of 
collagen I, fibrillin-1 or fibronectin, are likely responsible for the adhesion strength 
at the plaque-IEL interface. 
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Atherosclerotic plaque rupture can lead to myocardial infarction or ischemic 
stroke, two of the leading causes of death in the United States [1]. It is estimated 
that by 2030 there will be 3.4 million strokes in American adults, a 20% increase 
in prevalence since 2012 [2]. Atherosclerotic plaque rupture in the carotid artery 
can lead to stroke or transient ischemic attack (TIA), which affect approximately 
795,000 and 5 million people each year, respectively. Strokes are one of the top 
causes of long-term disability, while also accounting for one in every 19 deaths in 
the US [2].  
 Ischemic stroke can be induced by multiple mechanisms. One well-
established cause is plaque rupture, during which a tear in the fibrous cap of an 
atherosclerotic plaque exposes the highly thrombogenic necrotic core material. In 
some cases, the resulting thrombosis causes vessel occlusion, during which the 
patient will experience an ischemic stroke or TIA. Plaque rupture in the carotid 
artery accounts for approximately 15% of all ischemic strokes [88]. This 
mechanism generally occurs in lesions called a thin-cap fibroatheroma (TCFA), 
characterized by a thin fibrous cap covering a large necrotic core [20]–[23]. Though 
these morphological characteristics provide a good framework for identifying 
vulnerable plaques, the true test of plaque vulnerability is whether or not the 
mechanical strength of the tissue can withstand the physiological loading 
conditions to which it is subjected. When loads experienced in vivo exceed the 
mechanical strength of the fibrous cap, the tissue will fail, often resulting in 




plaque rupture varies. The thrombosis from plaque rupture may remain clinically 
silent if the thrombus does not completely occlude the vessel.  However, healing 
of the rupture sites within the fibrous cap promotes further occlusion of the vessel, 
and frequently subsequent ruptures or erosions of the fibrous cap occur [22], [23]. 
These subsequent ruptures or erosions may result in a clinical event. Therefore, 
identifying which fibrous caps are more likely to tear is a good predictor of which 
plaques are more likely to result in a clinical event. 
In order to predict likelihood of plaque rupture, the first step is to identify the 
best metric to assess fracture toughness of the fibrous cap.  While there is some 
information in the literature regarding quantitative measures of fibrous cap failure, 
such as ultimate tensile strength, the detailed failure mechanism of fibrous caps is 
not well understood. It is important to understand how the tissue fails in order to 
select the best method to assess the failure of these tissues. Examining the 
fracture behavior of the tissue will provide more insight into plaque rupture than 
previous studies.    
With regard to quantitative metrics,  several groups have previously used 
energy release rate to characterize fracture toughness in soft biological tissues, 
both in an adhesive layer [36], [37], [89], and within a biological tissue [30], [34], 
[35]. Though not used previously to characterize fracture toughness in vascular 
tissue, crack tip opening displacement (CTOD) was first proposed by Wells at the 
British Welding Institute to characterize failure in elastic-plastic yielding conditions 
[90]. Wells observed that plastic deformation resulted in blunting at the crack tip, 




of the material. Later, Dawes showed that CTOD is linearly related to the J-integral 
in elastic-plastic conditions and that both are valid fracture parameters [91]. 
Since the fracture toughness of fibrous caps has not been studied, this 
study aims to quantitatively characterize the fracture behavior of fibrous caps using 
both the CTOD metric and the stress in the un-cracked segment (UCS) to assess 
fracture toughness. To the authors’ knowledge this is the first application of CTOD 
in vascular tissue.  
4.2 Materials and methods 
4.2.1 Sample preparation and dissection 
The current study was approved by the IRB at Greenville Health System on 
September 3, 2013 and all patients gave written informed consent. In order to be 
considered for this study, patients must have greater than 50% stenosis in the 
carotid artery and a prior stroke or TIA, or greater than 70% carotid artery stenosis. 
Human carotid endarterectomy specimens were obtained from 8 patients at the 
time of surgery at Greenville Memorial Hospital (patient demographics in Table 
4.1). Two plaque specimens generated multiple samples from the same patients 
(Samples III and IV; Samples VII and VIII). The excised specimens were 
immediately immersed in Belzer UW Cold Storage Solution (Bridge to Life Ltd., 
Columbia, SC, USA) and were kept cool until testing. All mechanical testing was 
completed within 48 hours of tissue harvest. The intact specimen, shown in Figure 
4.1 (left), ranges from approximately two to five cm in length. The specimen is 




of the common carotid artery (CCA), the internal carotid artery (ICA), and the 
external carotid artery (ECA). The intact specimen was sliced into a series of 
transverse slices nominally 5-mm thick (Figure 4.1, right) using a custom slicing 
device. 





Region of Sample Used for Mechanical 
Testing 
I M 46 Carotid Bulb 
II F 89 Common Carotid Artery 
III M 84 Carotid Bulb 
IV M 84 Carotid Bulb 
V M 60 Carotid Bulb 
VI M 74 Carotid Bulb 
VII M 86 Internal Carotid Artery 
VIII M 86 Internal Carotid Artery 
IX F 74 Internal Carotid Artery 
X F 56 Carotid Bulb 
 
 
Figure 4.1 Typical examples of specimens obtained from carotid endarterectomy. 
An intact specimen immediately following harvest is shown on the left, with the 
common carotid artery at the bottom. The specimens are sliced into a series of 5 




4.2.2 Mechanical testing of isolated fibrous cap 
The fibrous cap was isolated for mechanical testing by dissection from the 
remaining plaque. All samples were subjected to tensile loading in the 
circumferential direction, corresponding to the direction of maximum wall stress 
(hoop stress). Two types of mechanical tests were performed. First, uniaxial tensile 
tests on the fibrous cap were performed to determine the stress-strain response of 
the fibrous cap. Then, the fracture behavior within the fibrous cap was examined. 
Immediately following the uniaxial tensile tests, a scalpel was used to introduce an 
initial flaw on one edge in the longitudinal direction, approximately at the midpoint 
between the two grips. The flaw orientation is nominally perpendicular to the 
longitudinal edge, with the loading applied parallel to the longitudinal edge (i.e., 
along the in-vivo circumferential direction). 
4.2.2.1 Experimental setup 
The isolated fibrous cap was mounted into a set of metal grips, with 100 grit 
sandpaper on the inner surface to minimize slippage. The grips were connected to 
a Bose 3200 Test Instrument (Bose Corp., Framingham, MA, USA). One grip was 
stationary and connected to a load cell, while the other grip was connected to an 
actuator. All experiments were performed in displacement control.  Both the 
uniaxial load and displacement were recorded at a rate of 2 Hz or higher during 
the experiment. Due to the unique geometry of each plaque specimen, in some 
cases the length of the isolated fibrous cap was very short (less than 15 mm). In 




Somerville, NJ, USA) (a topical skin adhesive) was added to the grips in order to 
further reduce the potential for specimen slippage within the grips.  
Two charge-coupled device (CCD) cameras (Grasshopper GRAS-50S5M, 
Point Grey Research, Richmond, BC, Canada) were positioned at a 90° offset from 
each other, one providing a front view and the other providing a side view of the 
tissue. Images were acquired at 1 Hz throughout each experiment. Small dots of 
black tissue marking dye were applied to the front face of the tissue in order to 
perform marker tracking and to measure the stretch ratio. The experiments were 
performed at a loading and unloading rate of 0.05 mm/s, with additional Belzer UW 
solution applied to the tissue at regular intervals (i.e., approximately every two 
minutes) during testing to prevent drying.  
4.2.2.2 Uniaxial tensile experiments 
Uniaxial tensile testing was performed to obtain the stress-strain response 
of the tissue. Cyclical displacements of approximately 20% - 30% of the specimen 
length were applied, resulting in global strains on the order of 0.20 to 0.30 during 
the cyclic strain process. The tissue was preconditioned through multiple loading 
and unloading cycles until the maximum load at the end of each cycle reaches 
steady state. The loading portion of the last cycle from each experiment was used 
to calculate the stress-strain response of the tissue. The stretch ratio was 
determined every second using the applied dot pattern. The Cauchy stress is 
determined by dividing the instantaneous force by the deformed cross-sectional 




measurements from the images captured by the cameras. The resulting 
experimental stress-strain data points were fitted by a second order polynomial 
hyperelastic model using Abaqus (Version 6.13-2, Dassault Systèmes Simulia 
Corp., Providence, RI, USA) material data fitting tools. 
4.2.2.3 Miniature single edge notch tension experiments 
 As discussed earlier, miniature single edge notch tension (MSENT) 
experiments were performed on plaque specimens that were prepared with an 
initial crack perpendicular to the direction of the applied load. In these studies, the 
initial crack length was between 45% and 70% of the overall width of the tissue. 
Cyclical controlled displacement was applied such that the crack extended slowly 
during several cycles of loading; each crack extension is approximately 0.4 mm in 
length. For the ten specimens where crack extension in the nominally longitudinal 
direction occurred from the notch root region, the crack tip opening displacement 
(CTOD) is obtained as the crack extends using images acquired during the 
MSENT experiments3. CTOD is calculated by measuring the distance between the 
intersections of a 90 degree vertex centered at the crack tip with the crack edges, 
as first suggested by Rice [92]; a schematic is shown in Figure 4.2. Additionally, 
the uniaxial average Cauchy stress in the UCS, σ, is determined at the initiation of 
tearing in each cycle as  
                                                          
3 Of the 34 specimens used in our experiments, 13 specimens (38%) failed in the grip 
region, 6 (18%) specimens failed in regions away from both the grips and the notch root 
and 5 (15%) specimens exhibited tearing across the thickness. Results from these 




𝜎 =  
𝐹
𝑤∗𝑡
                                                (4.1) 
where F is the instantaneous measured load, w is the instantaneous current 
remaining width of the UCS and t is the instantaneous current measured thickness 
in the UCS.  
 
Figure 4.2 A depiction of the CTOD measurement (left) and the geometry 
measurements required for the stress in the UCS calculations (middle and right). 
CTOD is calculated by measuring the distance between the intersections of the 
sides of a 90 degree vertex centered at the crack tip. The current cross-sectional 
area of the UCS is determined by measuring the current width (white line, center 
panel) and the current thickness (white line, right panel) of the UCS at the crack 













4.2.3 Histological studies 
 After mechanical testing, the samples were fixed in a solution of 4% 
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, embedded in paraffin, and 
sectioned at a thickness of 5 μm. The sections were stained in 0.1% Picrosirius 
Red (PSR) in saturated picric acid for 90 minutes, washed for 2 minutes in 0.01 M 
hydrochloric acid, dehydrated, cleared, and mounted in Permount. The sections 
were analyzed under cross-polarized transmitted light on a Zeiss Axio Imager 
microscope. A 10X objective lens was used to collect images from the samples. 
Images were captured with a Zeiss AxioCam CCD camera and analyzed for 
collagen content using Image-Pro Plus software (Version 5.1.0.20, Media 
Cybernetics, Rockville, MD, USA). 
 Collagen content was determined based on the fractional area of 
birefringence observed in the PSR-stained tissue sections. First, an image was 
collected in brightfield and the total tissue area was measured using Image-Pro 
Plus. Then the same field was examined under cross-polarized light and an image 
was collected. The area of the sample that showed green, yellow, or orange-red 
birefringence characteristic of collagen was then measured. The collagen content 
of the sample as a whole was calculated by comparing the birefringent area to the 
total tissue area. This analysis was applied to several regions of each section, as 
the sections are sometimes too large to be completely visualized at 10X 
magnification. Values of fractional collagen area from the different quadrants were 




4.2.4 Statistical analysis 
Data from multiple samples are reported in terms of the median, first quartile 
(IQR1), and third quartile (IQR3) values. Significant relationships between 
measured parameters were assessed using linear regression to test the null 
hypothesis that the slope is equal to zero. The null hypothesis was rejected, with 
statistical significance, if P < 0.05.   
4.3 Results 
4.3.1 Stress-strain curves 
Figure 4.3 presents the stress-strain curves for tensile loading of individual 
fibrous cap specimens. As shown in Figure 4.3, there is substantial scatter in 
material response that is consistent with previous observations [17-24]. In our 
studies, each specimen exhibits non-linear response that is typical of vascular 
tissue. Further study of the data shown in Figure 4.3 led the authors to extract 
subsets of the overall data that represent (a) the low-strain region and (b) the high-
strain region. The low and high strain data sets are separated by manually 
identifying the midpoint between the two regions, depicted in Figure 4.4. In 
addition, linear regression is performed on the data points in each of these subsets 
to identify the tangent modulus. Table 4.2 presents both the tangent moduli and 
the stretch ratio at which the shift between the two regions occurs. Results show 
that the median [IQR 1, IQR 3] low-strain tangent modulus is 63.1 [29.5, 87.0] kPa, 
the median [IQR 1, IQR 3] high-strain tangent modulus is 1006.6 [288.1 1805.1] 




sets is 1.13 [1.09, 1.15]. More detailed investigation of the data in Figure 4.3 
suggests that there are three major sub-groups in the stress-strain response; a stiff 
group (III, V), an intermediate group (II, VI, VII, VIII), and a compliant group (I, IV).  
 
Figure 4.3 The stress-strain response of several fibrous caps.  The dots represent 
experimental data points The solid curves represent predictions based on material 
model data fitting performed in Abaqus. 









I 60.7 142.8 1.15 
II 16.3 536.8 1.14 
III 90.9 1972 1.05 
IV 20.5 205.2 1.15 
V 75.4 2086 1.07 
VI 6.64 44.77 1.09 
VII 65.6 1303 1.18 
VIII 149.1 963.0 1.10 
IX 100.7 1050 1.16 











































Figure 4.4 The low-strain tangent modulus (LSTM), high-strain tangent modulus 
(HSTM) and the stretch ratio at shift are determined from the stress-strain curves. 
Data from the low-strain region and high-strain region of each stress-strain curve 
are fit by linear regression to determine the low-strain tangent modulus and high-
strain tangent modulus, respectively. The stretch ratio at shift is determined by 
identifying the stretch at the midpoint between the two regions. 
 
4.3.2 Crack tip opening displacement  
Figure 4.5 presents the CTOD measurements during crack extension for 
the plaque specimens. As shown in Figure 4.5, CTOD increases with increasing 
crack extension. This behavior is consistent with ductile materials that exhibit crack 
tip blunting. In these studies with relatively small specimens, the overall amount of 
crack extension is limited by the geometry of the sample and by the size of the 
initial crack. Inspection of the data in Figure 4.5 suggests that CTOD is a linearly 
increasing function of crack extension. The median [IQR 1, IQR 3] initial CTOD is 


































measurements is 1.30 [0.59, 1.51]. It is important to note that in almost all of the 
plaque specimens the initial CTOD values are clustered around 0.5 mm, with the 
exception of samples IV, VI and X, which have higher initial CTOD values (0.96 
mm, 2.73 mm, and 1.01 mm, respectively).  
 
Figure 4.5 The CTOD increases with crack extension (a) for each specimen. The 
dashed line shows a trendline through all CTOD data points.  
 
In addition to the CTOD measurements, the radius of curvature of the crack 
tip is quantified at the initiation of tearing for each sample as a metric for the degree 
of crack tip blunting. Two samples exhibited such a high degree of blunting that a 
90 degree vertex did not intersect the edges of the crack. In these cases, CTOD 
could not be calculated using the 90o intersection definition (a) for the entire 
































extension in sample VI. Even so, in all cases the radius of curvature of the crack 
tip at the initiation of tearing was measured. The median [IQR 1, IQR 3] radius of 
curvature of the crack tip at initial tearing is 0.24 [0.13, 0.27] mm. 
4.3.3 Stress in the un-cracked segment 
Stress in the UCS was calculated at the initiation of tearing for each cycle, 
with median [IQR 1, IQR 3] values of 0.366 [0.279, 0.648] MPa. The stress in the 
UCS is plotted versus crack extension in Figure 4.6. There appear to be two groups 
of responses. One group (I, V, VII) has a high initial stress in the UCS, followed by 
much lower stresses at the initiation of additional crack extension. The other group 
(II, VI, VIII, IX, X) has relatively constant stresses in the UCS. Samples III and IV 
only had one cycle of tearing and therefore only one stress calculation.  
 
Figure 4.6 Stress in the UCS versus crack extension for each specimen. Samples 













































The initial decrease in stress in the UCS in samples I, V, and VII could arise 
from calcification, local variations in collagen content, or varying orientation of 
collagen fibers. Additionally, when Figure 4.5 and Figure 4.6 are compared it is 
clear that CTOD and stress in the UCS are not directly related. While CTOD is a 
strictly increasing function of crack extension, stress in the UCS is essentially 
constant, after an initial decrease in some cases.  
4.3.4 Collagen content trends 
 Collagen content was measured in each specimen after mechanical testing 
and compared to patient age, initial stress in the UCS, initial CTOD, and initial 
radius of curvature at the crack tip (Figure 4.7, Table 4.3). The median [IQR 1, IQR 
3] value of fractional collagen content is 32.8 [30.0, 42.0] percent. While there is a 
slight decrease in collagen content with age, this is not a significant relationship. 
However, there is a statistically significant relationship between collagen content 
and the stress in the UCS (P = 0.003 that slope is zero).  In addition, there is a 
statistically significant inverse trend between the initial CTOD value and total 
collagen content (P = 0.019). 
The effect of collagen content on CTOD at fixed values of crack extension 
was assessed and no significant trends were found (Figure 4.8), suggesting that 
other material constituents may be responsible for the slope of the CTOD curve, 
or rate of crack tip blunting. The radius of curvature at the crack tip, which is a 
measure of the degree of blunting at the crack tip, also is shown to have a 




results suggest that samples with higher collagen content begin tearing with a 
sharper, narrower crack and exhibit higher stresses at the initiation of tearing.  
 
 
Figure 4.7 The effect of total collagen content on age, initial stress in the UCS, 
initial CTOD and initial radius of curvature of the crack tip. While total collagen 
content generally decreases with age, this is not a significant trend (top left). There 
is a significant linearly direct relationship between the stress in the UCS and total 
collagen content (P < 0.05) (top right).  The initial CTOD decreases with increasing 
total collagen content and this is a statistically significant relationship (P < 0.05) 
(bottom left). There is a statistically significant inverse linear relationship between 
the initial radius of curvature of the crack tip and the total collagen content (P < 



















































































































Table 4.3 Summary of key statistical relationships between selected parameters 
 
 
4.3.5 Other observations of tissue behavior 
 During the MSENT experiments, the crack tip exhibited blunting in each 
sample.  Figure 4.9 shows a representative series of images of the crack both 
before and during tissue failure. The radius of curvature of the crack tip is 
measured at the initiation of tearing for each cycle. The radius of curvature of the 
crack tip increased with each consecutive cycle in every specimen, showing that 
the degree of crack tip blunting increases with crack extension. Wells noted that 
crack tip blunting increased directly with an increase in toughness of the material 
[90]. To examine whether or not our results also show this trend, the initial CTOD 
and the initial radius of curvature of the crack tip were compared. We find a 
significant direct correlation (P = 0.038), shown in Figure 4.10, that matches Wells’ 
observations.  
Parameter 1 Parameter 2 Relationship 
Statistically 
Significant 
Collagen Content Age Inverse Linear No (P = 0.425) 
Collagen Content Initial CTOD Inverse Linear Yes (P = 0.019) 
Collagen Content 
Initial Stress in 
the UCS 
Direct Linear Yes (P = 0.003) 
Collagen Content 
Initial Radius of 
Curvature at the 
Crack Tip 
Inverse Linear Yes (P = 0.009) 
Initial Radius of 
Curvature at the 
Crack Tip 





Figure 4.8 Collagen content versus CTOD at selected crack extension values. The 
CTOD at selected values of crack extension is determined by linear interpolation 
for each specimen. These values are plotted versus collagen content to determine 
if collagen content affects CTOD values at other crack extensions. Collagen 
content versus initial CTOD (before crack extension) is shown in Figure 4.7. None 













































































Figure 4.9 Blunting of the crack tip progresses as the tissue tears. The first row 
shows the initial, intact specimen (a), the specimen immediately after the notch is 
made (b), and the specimen during the deformation before tearing initiated (c-f). 
The bottom row shows the progression of blunting as tearing progresses in the 
tissue (a-f). 
 
Figure 4.10 The initial radius of curvature of the crack tip and the initial CTOD 



































 To the authors’ knowledge, this is the first study that has investigated the 
fracture behavior of fibrous cap tissue and the first to use CTOD as a fracture 
parameter in vascular tissue. The results show that collagen content plays a 
significant role in determining the material’s fracture response, in terms of stresses 
observed at fracture, CTOD, and blunting of the crack tip. These results suggest 
that collagen fibers are responsible for increasing the load-bearing capacity of 
fibrous caps and resisting plastic deformation of the crack tip during fibrous cap 
failure.   
4.4.1 Validity of results 
Obtaining valid fracture toughness measurements in soft biological 
materials is inherently difficult, primarily due to limitations of specimen size. The 
results in this study show that CTOD increases with crack length, due to an 
increase in blunting of the crack tip with each increment of crack extension. There 
is no observable significant change in CTOD when the initial crack length is varied. 
While the size limitations of fibrous cap specimens make it difficult, if not 
impossible, to obtain adequate samples for ASTM standardized testing for fracture 
toughness experiments, these results can still be used to add to the understanding 
of fibrous cap failure. Atherosclerotic fibrous caps are notoriously heterogeneous 
tissues [93]. For this reason, a metric that can provide insight into the relative 
mechanical strength of fibrous caps is beneficial. The fracture parameters 




samples from different patients and to infer which fibrous caps are more likely to 
rupture under specific loading conditions.  
4.4.2 Effect of collagen content 
The fibrous cap is composed of smooth muscle cells, macrophages, and an 
extracellular matrix made up primarily of collagen and proteoglycans [20]. Collagen 
type I and collagen type III are the primary structural components [94] in fibrous 
caps and are responsible for much of the mechanical response of the tissue. The 
results from this study show that collagen content plays a significant role in the 
blunting of the crack tip at crack initiation and in the magnitude of stress in the UCS 
that is required to initiate tearing. These results predict that a fibrous cap with 
higher collagen content will fail at a higher stress with a sharper crack and a lower 
initial CTOD. Previous studies have shown that increased collagen content in 
fibrous caps leads to a greater stress at tearing and decreased extensibility of the 
tissue [95], [96]; these trends are consistent with our observations. 
Fibrous caps can be viewed as a fiber-reinforced material with collagen 
fibers embedded in the surrounding extracellular matrix.  Since collagen is the 
primary load bearing protein in the ECM of the fibrous cap, and the remaining 
matrix is much weaker than the collagen fibers, the non-collagenous matrix will be 
more compliant in achieving plastic deformation and blunting of the crack tip. In 
this context, an abundance of collagen fibers will require either breakage of the 
collagen fibers or debonding between the fibers and the matrix for the crack tip to 




are aligned parallel to the direction of loading (circumferential orientation), as seen 
in the arterial media, then the fibers will increase tensile strength and resist crack 
tip blunting prior to the initiation of tearing. However, if collagen fibers are oriented 
perpendicular to the loading direction (longitudinal orientation), they will have very 
little impact on the material response. In this case, the mechanical response will 
be controlled by the interactions between the fibers and the remaining extracellular 
matrix, rather than by the fibers themselves. The collagen fiber organization has 
not been examined in this study and is relevant future work. Generally, collagen 
organization is assumed to be isotropic in the fibrous cap. However, if this is not 
the case, the organization of the collagen fibers will play a critical role in 
characterizing the material response of fibrous cap tissue.  
While collagen content significantly affects the initial CTOD and the initial 
stress in the UCS, the importance of collagen content may diminish with crack 
extension. Figure 4.8 shows that collagen content has no effect on CTOD beyond 
the initial crack extension. Figure 4.6 demonstrates that the range in magnitude of 
stress in the UCS is reduced with additional crack extension. Collagen content may 
be a good predictor of the initial failure conditions only. After the initial increment 
of crack growth, other unidentified material constituents may be responsible for the 
fracture behavior. 
This study was a portion of a larger study on mechanical properties of 
atherosclerotic plaque tissue. Mechanical test data and histological results from 




4.4.3 Notch sensitivity 
 The effect of the presence of a notch on the mechanical strength of a 
material oftentimes is measured by the notch sensitivity ratio (NSR). NSR is the 
ratio of the notch strength, or stress required to tear the material when a notch is 
present, to the ultimate tensile strength (UTS), which is the stress at which failure 
initiates in an un-cracked material. A NSR of 1 is indicative of a material that is not 
weakened by the presence of a notch and is known as  a notch-insensitive material 
[97], [98]. Ideally, the tensile strength would be measured in an un-cracked 
specimen and in a cracked specimen with the same material properties, and the 
results would be compared pairwise. This approach is logistically difficult in fibrous 
cap tissue due to the small size of the specimens and heterogeneity of material 
properties. Even samples from the same patient can have noticeably different 
results (for example: samples III and IV, samples VII and VIII in this study). 
Since our current study has not obtained ultimate tensile strength data for 
the small plaque specimens, previous results from the literature may provide some 
insight. A few studies measured the UTS of whole plaque specimens [46]–[48] and 
at least one study measured UTS in isolated fibrous cap tissue [54]. Teng et al. 
report a median [IQR 1, IQR 3] UTS of 0.158 [0.0721, 0.259] MPa in fibrous caps 
from symptomatic patients [54], which is much lower than the stress 
measurements presented in this study of 0.366 [0.279, 0.648] MPa in fibrous caps 
from asymptomatic patients. These results suggest a NSR of approximately 2.3, 
which is indicative of a notch-strengthening material. It should be noted that an 




properties between plaques from symptomatic versus asymptomatic patients, 
rather than the effect of the notch. Future work should include measuring the UTS 
of fibrous caps from asymptomatic patients. Additionally, the frequent observation 
of failure away from the crack tip supports the idea of a relatively high NSR (≥ 1). 
In such cases, tissues with a higher NSR do not have a significant stress 
concentration at the crack tip. Therefore, the material is not predisposed to fail 
preferentially at the notch tip. It is further noted that notch insensitivity or defect 
tolerance is expected to occur in highly fibrous tissues with a relatively uniform 
fiber orientation when loaded parallel to the predominant fiber direction. If the 
bonding between fibers is relatively poor, then the stress cannot be transmitted 
between fibers and the tissue essentially acts as a series of independent fibers 
[99]. 
Clinically, notch insensitivity could be a very beneficial material behavior for 
fibrous caps. If a flaw does not create a stress concentration in the fibrous cap, this 
gives the tissue an opportunity to heal over time, as long as the critical fracture 
criterion is not exceeded during the healing process. For example, if high blood 
pressure is experienced for a short time and a small tear occurs in the fibrous cap, 
the event may remain clinically silent since the tear will not readily propagate. If 
the blood pressure is then lowered, the fibrous cap could repair this tear over time 
without an increased risk for future plaque rupture events. However, if high blood 
pressure is uncontrolled and maintained long term, the critical failure criterion of 
the tissue may be exceeded and the tissue could continue to tear, resulting in a 




not consider the effects of material fatigue, which may also play a significant role 
in plaque rupture.   
4.4.4 Fracture parameters for fibrous caps 
Materials that fracture at a higher stress are considered to be stronger than 
materials that fracture at a lower stress. A material with a higher CTOD is 
considered more resistant to fracture than a material with a lower CTOD. The 
results from this study show that tissues with greater collagen content fail at a 
higher stress and a smaller CTOD than those with a lower collagen content. These 
divergent fracture parameters suggest a conflicting ranking for the fracture 
resistance of fibrous caps. Generally, fibrous cap stability has been assessed by 
the stress at which failure occurs, rather than the CTOD or the strain, but our 
results and the following discussion suggest that stress may not always be the 
most appropriate metric to use. Plaque rupture will occur when the fibrous cap 
tissue cannot withstand the loading conditions imposed upon it. While collagen-
rich fibrous caps are able to withstand higher forces, they are less extensible. 
Deformation of an artery, particularly the carotid artery from which these samples 
are obtained, is important in vascular health. If the fibrous cap is significantly stiffer 
than the underlying media and unable to deform to the same extent, the 
discrepancy in material properties may lead to plaque dissection at the shoulders, 
a prominent event during balloon angioplasty [24]–[26]. This effect has also been 
demonstrated in a finite element model where the plaque tissue is approximately 
one order of magnitude stiffer than the medial layer [100]. A mismatch in material 




of plaque ruptures at the plaque shoulders. Conversely, fibrous caps with lower 
collagen content may deform more readily with the underlying media but may fail 
at lower stress values.  
Ultimately, the optimal fracture parameter for assessing plaque vulnerability 
will depend on the material properties of the fibrous cap, rather than the conditions 
to which it is subjected. Our results do not show which fracture parameter will be 
best suited for certain situations, such as high stress (high blood pressure) or high 
strain (balloon angioplasty, for instance). Instead, our results indicate that fibrous 
caps with higher collagen content are stiffer and will likely reach the critical CTOD 
before reaching the critical stress, suggesting that CTOD is the appropriate 
fracture parameter. Conversely, fibrous caps with lower collagen content will fail at 
a lower stress and therefore stress may be the relevant fracture parameter. For 
fibrous caps with an intermediate, or unknown, collagen content, it may be 
necessary to evaluate both fracture parameters. 
Knowledge of the collagen content in the fibrous cap can give insight into 
the failure behavior of the material. Time-resolved laser induced fluorescence 
spectroscopy, a catheter-based imaging technique, has been shown to detect 
collagen content in atherosclerotic plaques [101]. This technique may be useful in 
determining collagen content, and thereby estimating material behavior of the 
fibrous cap, prior to clinical intervention. In particular, an estimation of the plaque 
mechanical properties could help assess the optimal treatment for carotid artery 
stenosis. Carotid endarterectomy (CEA) is generally considered the standard 




been suggested as an alternative, less invasive, technique. CAS has been shown 
to result in more strokes during the periprocedural period than CEA [27]–[29], 
which may be a result of the high strain applied on fibrous caps with high collagen 
content during balloon angioplasty. This increased risk of stroke during the 
periprocedural period may be reduced if the material properties of the plaque are 
considered prior to selecting a treatment. While CAS may be a suitable alternative 
to CEA in some cases, CAS may not be the optimal treatment for patients with 
high collagen content in the fibrous cap.  
4.5 Conclusions 
 This study shows, for the first time, that CTOD can be used as a 
comparative metric for fracture toughness in atherosclerotic fibrous cap samples 
from individual patients. Collagen content is important in determining the 
mechanical behavior and response of fibrous caps in atherosclerosis. A fibrous 
cap with higher collagen content fails at a higher stress and lower CTOD than 
fibrous caps with lower collagen content. Furthermore, high collagen content is 
associated with a sharper crack tip, suggesting that collagen fiber-rich tissue 
impedes blunting of the crack tip. Additionally, the results suggest that fibrous caps 
may exhibit notch insensitivity or even notch strengthening behavior. Lastly, these 
results show that analyzing the stress in fibrous caps provides only one part of the 
picture when considering the problem of plaque rupture. The strain, or deformation, 
which a fibrous cap is able to withstand is also an important aspect of plaque 
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The overall aim of this project was to use fracture mechanics concepts to 
characterize atherosclerotic plaque failure. To achieve this goal, fracture 
toughness was measured in both mouse and human plaques to assess adhesion 
strength and during tearing failure of human fibrous caps from carotid 
endarterectomy specimens. In addition, failure behavior of thin protein films was 
studied in vitro to measure the adhesion strength of selected proteins,  
The adhesion strength between atherosclerotic plaques and IEL as well as 
the failure load are unchanged between ApoE-/- and ApoE-/- Col8-/- mice. However, 
the plaques in ApoE-/- Col8-/- mice are less stiff than those in ApoE-/- mice. While 
human atherosclerotic plaques are much stronger than those found in mice, the 
plaque adhesion strength data sets are qualitatively similar, in terms of having 
positively skewed distributions of energy release rate and standard deviations 
which are approximately equal to the means.  
Investigating the plaque-IEL interface further, this study shows that 
contributions of adhesive matrix proteins to the strength of the plaque-IEL interface 




combined with RDCB experiments shows that collagen IV alone is not likely to be 
responsible for the adhesive strength of the plaque-IEL interface. SEM images of 
a partially delaminated plaque show bridging fibers that connect the plaque and 
the IEL. The adhesive strength of the plaque-IEL interface likely derives from 
tensile strength of these bridging fibers, potentially composed of collagen I, fibrillin-
1, or other structural matrix proteins, rather than from protein adhesion/cohesion. 
To characterize plaque susceptibility to tensile rupture of the fibrous cap, 
this study investigated the fracture toughness of human fibrous caps. The results 
show, for the first time, that CTOD can be used as a comparative metric for fracture 
toughness in atherosclerotic fibrous cap samples from individual patients. 
Collagen content is important in determining the mechanical behavior and 
response of fibrous caps in atherosclerosis. A fibrous cap with higher collagen 
content exhibits more brittle behavior and fails at a higher initial stress and lower 
initial CTOD than fibrous caps with lower collagen content. Collagen fibers act to 
impede blunting of the crack tip and increase tensile strength of the tissue. 
Knowledge of the collagen content in the fibrous cap prior to surgical intervention 
could predict the mechanical response of the fibrous cap and aid in determining 
the optimal treatment plan. 
Fracture toughness was used to assess plaque resistance to two different 
failure mechanisms: 1) plaque delamination at the plaque-IEL interface and 2) 
tensile rupture of the fibrous cap. Collagen is a vital structural component of 
atherosclerotic plaques and is crucial in determining the mechanical response of 




proteins, such as fibrillin-1, are likely responsible for the mechanical strength of the 
plaque-IEL interface.  
5.2 Future Studies 
 There are several questions that arise from the results of the current study. 
The results from Chapter 3 show that collagen IV is too weak to account for the 
mechanical strength of the plaque-IEL interface in mice, measured in situ in 
Chapter 2. However, these results do not rule out all adhesive proteins as 
contributors to the mechanical strength at the plaque-IEL interface and therefore 
the mechanical strength of other adhesive proteins should be investigated. 
Additionally, the technique we used does not distinguish between adhesive 
strength between the protein and the underlying matrix and cohesive strength 
within the protein layer. If adhesive proteins are responsible in part for the 
mechanical strength of the plaque-IEL interface, distinguishing between cohesive 
strength and adhesive strength will be important in understanding the detailed 
failure mechanism.    
While all adhesive proteins have not been excluded as potential contributors 
to plaque-IEL bonding, the role of bridging fibers at the plaque-IEL interface should 
also be investigated. Specifically, the number, diameter, and composition of these 
bridging fibers should be further investigated with immunogold SEM. Additionally, 
the mechanical strength of these bridging fibers should be investigated and 




 The results from Chapter 4 describe an interesting characterization of 
fibrous cap mechanical properties. The initial failure criteria can be predicted by 
collagen content; however, this trend no longer exists with additional crack 
extension. This change may be due to a movement or realignment of the collagen 
fibers ahead of the crack tip as the crack extends. Fiber realignment could be 
investigated using second-harmonic generation (SHG) microscopy to view 
collagen fiber organization after a small increment of crack growth.   
If collagen fibers are in fact realigning during crack extension, the effect of 
displacement rate on the experimental results should also be investigated. The 
strain rate in vivo is much higher than the displacement rate of the experiments, 
and the slower experimental displacement rate may allow the tissue a chance to 
respond to crack extension, potentially by fiber realignment, which does not exist 
in vivo. 
The degree of fiber realignment may be constrained by the relative stiffness 
of the surrounding non-collagenous matrix. For this reason, other constituents of 
the fibrous cap, such as macrophages, SMCs, and proteoglycans, should be 
investigated. 
The ECM constituents quantified in plaque tissue should be related to the 
mechanical response of these tissues obtained from uniaxial tensile tests 
performed on the same specimens (see Appendix A). Specifically, the Holzapfel-
Gasser-Ogden (HGO) model parameters should be determined for each sample 




tissue type can be created by combining the HGO parameters with the material 
constituents in each sample. These results will be particularly useful to the 
computational modeling community as there is limited data available in the 
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APPENDIX A  
ADDITIONAL MECHANICAL TEST DATA AND HISTOLOGICAL 
RESULTS FROM HUMAN ATEROSCLEROTIC PLAQUES
 Chapter 4, a study on the fracture resistance of atherosclerotic fibrous caps, 
was a portion of a larger study on mechanical properties of atherosclerotic plaque 
tissue. This appendix presents additional mechanical test data and histological 
studies performed on human atherosclerotic plaque tissue. 
Mechanical testing was performed on strips of isolated fibrous cap (FC), 
media underlying atherosclerotic lesions (diseased media, DM), and media from 
relatively healthy sections of tissue (normal media, NM). Stress-strain curves 
obtained from uniaxial tensile experiments performed on strips of atherosclerotic 
plaque tissue (see section 4.2.2.2 for full experimental methodology) are presented 
in Figure A.1.  
There is a lot of scatter both within and between tissue types, similar to 
section 4.3.1. However, the average diseased media specimen is somewhat stiffer 
than the average normal media specimen. The mechanical response of the fibrous 
cap specimens is similar to that of the media specimens. After mechanical testing, 
each specimen was fixed in 4% paraformaldehyde in phosphate buffer and stored 






Figure A.1 Stress-strain relationships for strips of isolated normal media, diseased 
media, and fibrous cap from human carotid endarterectomy specimens. 
 
Collagen content and elastin content were determined in each fixed sample 
saved following mechanical testing using standard histological techniques. 
Collagen content was determined in each sample by staining with Picrosirius Red 
(PSR) and following the protocol in section 4.2.3. Additionally, elastin content was 
determined by staining with Verhoeff solution and calculating the area of black 
tissue (elastin) relative to the total tissue area. Representative images of trichrome 
staining, PSR staining, and Verhoeff staining are shown in Figure A.2 for each 
tissue type. The histology performed on normal media (top row) shows some 
intimal thickening is present in this tissue, most clearly visible in the Verhoeff stain 
(right column). This is not surprising as this tissue is immediately adjacent to 
advanced atherosclerotic lesions and therefore is likely to exhibit some 



































Figure A.2 Representative trichrome (left column), Picrosirius Red (middle column) 
and modified Verhoeff (right column) staining for normal media (top row), diseased 
media (middle row) and fibrous cap (bottom row). Scale bars represent 100 μm. 
 
The results from quantification of the histological images from 5 specimens 
per tissue type are shown in Figure A.3 and Table A.2. One way ANOVA confirms 
that there are significant differences in both collagen and elastin content between 
tissue types. Tukey’s Honestly Significant Different test confirms that collagen 
content in the fibrous cap is significantly different from both normal and diseased 
media. The elastin content in the fibrous cap is significant different from that the in 
normal media, but not the diseased media. There are no significant differences in 





Figure A.3 Collagen and elastin content in normal media (NM), diseased media 
(DM), and fibrous cap (FC). Error bars represent standard deviation. 
 
Table A.1 Summary of histological results for each tissue type 
 
Tissue Sample ID Collagen % Elastin % 
Normal Media 
NM1 22.1 7.0 
NM2 36.0 11.5 
NM3 12.0 17.7 
NM4 12.1 30.6 
NM5 18.4 16.5 
Average 20.1 ± 9.8 16.7 ± 8.9 
Diseased Media 
DM1 32.5 5.8 
DM2 26.3 6.0 
DM3 6.3 25.1 
DM4 18.4 5.7 
DM5 7.7 17.3 
Average 18.3 ± 11.4 12.0 ± 8.9 
Fibrous Cap 
FC1 30.4 0.72 
FC2 37.6 0.57 
FC3 38.5 1.3 
FC4 39.8 1.1 
FC5 43.4 1.9 
Average 37.9 ± 4.8 1.1 ± 0.5 
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